Otic Regeneration and Development: Advancement of Stem Cell-Based Methodology for In Vitro Modeling of Mammalian Inner Ear Sensory Epithelia by Schaefer, Stacy
 Otic Regeneration and Development: Advancement of Stem Cell-Based Methodology for 
In Vitro Modeling of Mammalian Inner Ear Sensory Epithelia 
 
 
by 
 
Stacy A. Schaefer 
A dissertation submitted in partial fulfillment 
 of the requirements for the degree of  
Doctor of Philosophy 
(Neuroscience) 
in the University of Michigan 
2018 
Doctoral Committee: 
Associate Professor Robert K. Duncan, Chair 
Professor Gregory R. Dressler 
Associate Professor David C. Kohrman 
Professor Yehoash Raphael 
Professor Linda C. Samuelson 
Professor Michael D. Uhler
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stacy A. Schaefer 
sschaef@umich.edu 
ORCID iD: 0000-0002-6190-7031 
 
© Stacy A. Schaefer 2018
ii 
Dedication 
 
 
For their constant support, this dissertation is dedicated to 
Gary Schaefer, father 
Hollie Schaefer, mother 
Scott Schaefer, brother 
 
And, with extraordinary gratitude, to 
Kyle Pentecost, husband 
 
As well as to our family and friends. 
iii 
Acknowledgments 
 
 
The work described in this thesis was possible due to the support of my mentor, 
Dr. R. Keith Duncan.  He simultaneously encouraged my creativity and focused my 
ambitions to fit the scope of a graduate thesis.  I am extremely grateful for the 
opportunities to learn, to grow, and to pursue my lofty goals in his lab. 
I am also grateful to my committee.   When I was lost in a tangle of details, they 
helped me disengage so that I could see the bigger picture.  Their perspicacity was 
much appreciated.  Ultimately, their questions and comments challenged me to achieve 
my best work. 
Special thanks go to lab manager Liqian Liu for her tireless efforts facilitating my 
experiments and those of everyone in the lab.  Her ability to maintain a long and varied 
list of commitments with patience and generosity is extraordinary. 
Special thanks also go to Neuroscience Graduate Program director Dr. Edward 
Stuenkel for his invaluable guidance.  I would also like to acknowledge the 
Neuroscience Graduate Program and Kresge Hearing Research Institute for supporting 
my progress in so many ways. 
Additionally, I am grateful for the following sources of funding for my training and 
research: NIH T32-NS076401 (Early Stage Training in the Neurosciences), NIH T32-
DC00011 (Hearing, Balance, and Chemical Senses Predoctoral Training Grant), and 
DoD USAMRMC W81XWH-12-1-0492.
iv 
Table of Contents 
 
Dedication ........................................................................................................................ii 
Acknowledgments ........................................................................................................... iii 
Lists of Tables ................................................................................................................ vii 
Lists of Figures .............................................................................................................. viii 
Glossary of Common Terms/Abbreviations .....................................................................ix 
Abstract ........................................................................................................................... x 
CHAPTER 1:  Introduction .............................................................................................. 1 
STRUCTURE AND FUNCTION OF THE INNER EAR ........................................................... 2 
STEM CELL REGENERATION OF INNER EAR HAIR CELLS............................................... 5 
TAKING CUES FROM THE MAMMALIAN EMBRYONIC INNER EAR ..................................11 
Early TGFβ inhibition favors ectodermal lineage by inhibiting formation of mesoderm and 
endoderm...........................................................................................................................12 
Role of BMP4 in inhibiting default neural ectodermal fate, promoting non-neural ectoderm
 ..........................................................................................................................................16 
Two-step commitment to preplacodal fate: Elevation and subsequent attenuation of BMP 
signaling at the border between neural and non-neural tissues ..........................................18 
FGF2 recapitulates the otic induction stage of development, when inner ear progenitors 
commit to otic fate ..............................................................................................................21 
SHH/Pax2 mediates cochlear duct outgrowth as Wnt/Sox2 regulates the prosensory 
domain ...............................................................................................................................26 
Hair cell markers for monitoring in vitro differentiation yields ..............................................29 
SUMMARY OF EXPERIMENTS ............................................................................................31 
CHAPTER 2:  Pax2EGFP cell line illuminates key stages of development in mouse inner 
ear organoid model ....................................................................................................... 33 
INTRODUCTION ...................................................................................................................33 
MATERIALS AND METHODS ...............................................................................................35 
Mice ...................................................................................................................................35 
Auditory brainstem response (ABR) recording ...................................................................36 
Derivation of Pax2EGFP mouse embryonic stem cells ..........................................................37 
mESC cultures ...................................................................................................................37 
Differentiation protocol .......................................................................................................38 
v 
Immunostaining..................................................................................................................39 
FM 4-64FX labeling ............................................................................................................41 
Aminoglycoside treatment ..................................................................................................42 
FGF assay .........................................................................................................................42 
Western blotting .................................................................................................................43 
Vesicle and organoid quantification ....................................................................................43 
Aggregate size measurements ...........................................................................................44 
Statistical analysis ..............................................................................................................44 
RESULTS ..............................................................................................................................44 
Pax2EGFP/+ mice develop normal inner ears ........................................................................45 
Pax2EGFP/+ mESCs form inner ear organoids ......................................................................46 
Otic induction during organoid protocol supports FGF-ERK-Pax2 mechanism ...................54 
Pax2EGFP/+ organoids model several features of developing ear .........................................56 
Vesicle-associated neurons model features of embryonic inner ear neurogenesis .............60 
DISCUSSION ........................................................................................................................63 
Tracking protocol efficiency is necessary for optimization ..................................................67 
CHAPTER 3:  Early inhibition of TGFβ signaling is necessary for derived otic vesicles to 
achieve ultimate inner ear organoid fate ....................................................................... 70 
INTRODUCTION ...................................................................................................................70 
MATERIALS AND METHODS ...............................................................................................72 
mESC cultures ...................................................................................................................72 
Differentiation protocol .......................................................................................................73 
Quantification of vesicles and organoids ............................................................................74 
Immunostaining..................................................................................................................75 
Statistical analysis ..............................................................................................................76 
Isolation of derived vesicles for RNASeq ...........................................................................76 
Dissection of embryonic vesicles .......................................................................................77 
RNA sequencing ................................................................................................................77 
Data analysis .....................................................................................................................78 
Data availability ..................................................................................................................78 
RESULTS ..............................................................................................................................79 
R1/E mESCs produce otic vesicle-like and organoid structures .........................................79 
TGFβ signaling inhibition by SB431542 is not necessary for derived otic vesicles .............82 
TGFβ signaling inhibition is necessary for inner ear organoids ..........................................85 
vi 
Vesicles derived from SB431542-treated cultures approach native otic vesicle 
transcriptome .....................................................................................................................87 
DISCUSSION ........................................................................................................................92 
CHAPTER 4: Discussion of key findings and ongoing studies .................................... 106 
DISCUSSION OF KEY FINDINGS ...................................................................................... 106 
ONGOING STUDIES ........................................................................................................... 114 
Appendix ..................................................................................................................... 120 
Supplemental Figures and Tables ....................................................................................... 120 
Bibliography ................................................................................................................ 127 
vii 
Lists of Tables 
 
Table 1: Basic strategies and outcomes of stem cell protocols for hair cell production ... 9 
Table 2: Developmental stages recapitulated in inner ear organoid protocol ................ 13 
Table 3: Components and regulators of TGFβ superfamily signaling pathways ............ 15 
Table 4: Pax2 and Pax8 mutant mouse phenotypes ..................................................... 25 
Table 5: Recommended strategy to adopt inner ear organoid protocol ......................... 69 
Table 6: Quality of RNA input and base call output ....................................................... 89 
Table 7: Sequence quality determined by Fastqc and Trim Galore! .............................. 90 
Table 8: Alignment of BAM file reads to annotated transcripts ...................................... 91 
Table 9: GO analysis of biological processes of differentially expressed (DE) genes ... 95 
 
Table S1: Antibodies and stains used in Chapter 2 ..................................................... 123 
Table S2: Antibodies and stains used in Chapter 3 ..................................................... 124 
Table S3: Analysis of genes with fold change at least 1.5 and p<0.05  ....................... 125 
viii 
Lists of Figures 
 
Figure 1: Anatomy of the ear ........................................................................................... 2 
Figure 2: General schematic of organoid differentiation ................................................ 12 
Figure 3: Simplified TGFΒ signaling pathway ................................................................ 14 
Figure 4: Spatiotemporal inhibition of BMP4 in patterning neural and non-neural 
ectoderm ....................................................................................................................... 21 
Figure 5: Features of Pax2EGFP reporter system and characterization of Pax2EGFP/+ mice 
and WT controls at 4 weeks .......................................................................................... 48 
Figure 6: Establishment of Pax2EGFP/+ mESC line ......................................................... 50 
Figure 7: Process of forming Pax2EGFP/+ organoids ....................................................... 52 
Figure 8: Evidence of ERK mediating FGF-driven otic induction in mouse organoid 
model ............................................................................................................................ 57 
Figure 9: Characterization of Pax2+ inner ear organoids ............................................... 59 
Figure 10: Comparison of immunofluorescence staining for Isl1 and SHH in day 12 
aggregates and E11.5 embryos .................................................................................... 61 
Figure 11: Formation of organoids from R1/E cell line .................................................. 80 
Figure 12: Comparison of TGFβ pathway inhibitor effects at vesicle stage of 
differentiation ................................................................................................................. 82 
Figure 13: Comparison of TGFβ pathway inhibitor effects at organoid stage of 
differentiation ................................................................................................................. 86 
Figure 14: Differential expression analysis of day 12 derived and E10.5 embryonic otic 
vesicles ......................................................................................................................... 93 
Figure 15: Genes from GO term inner ear development ............................................... 96 
Figure 16: Model of relationship between RA, Tbx1, and Otx1 ................................... 102 
Figure 17: Preliminary testing of brainstem coculture.................................................. 115 
Figure 18: Implantation of R1-EGFP mESCs and derived otic progenitors into deafened 
guinea pig cochlea ...................................................................................................... 117 
Figure 19: Evaluation of gene expression changes with SHH pathway modulators in 
derived otic vesicles .................................................................................................... 118 
 
Figure S1: Tracking increase in aggregate diameter during ectodermal differentiation 
phase .......................................................................................................................... 120 
Figure S2: Tracking inner ear organoid culture success rate with Pax2EGFP/+ mESCs 121 
Figure S3: Early aggregate morphologies with and without SB431542 ....................... 122 
ix 
Glossary of Common Terms/Abbreviations 
 
ABR Auditory brainstem response 
AVE Anterior visceral endoderm 
BFL BMP4, FGF2, LDN193189 
BMP Bone morphogenetic protein 
BSFL BMP4, SB431542, FGF2, LDN193189 (ectodermal differentiation cues) 
CHIR99021 Wnt agonist (GSK3β inhibitor) 
CNS Central nervous system 
ECAD E-cadherin 
EGFP Enhanced green fluorescent protein 
F-actin Filamentous actin 
FGF Fibroblast growth factor 
GO Gene ontology 
hESC Human embryonic stem cell 
Isl1/2 Islet-1/2 
KSR KnockOut serum replacement 
LDN193189 BMP inhibitor 
mESC Mouse embryonic stem cell 
Myo7a Myosin 7a 
NDS Normal donkey serum 
OV Otic vesicle 
PBS Phosphate-buffered saline 
PCA Principal component analysis 
pERK Phosphorylated ERK 
PFA Paraformaldehyde 
PPE Preplacodal ectoderm 
RA Retinoic acid 
RNASeq RNA sequencing 
SFEBq Serum-free floating culture of embryoid body-like aggregates with quick 
reaggregation 
SHH Sonic hedgehog 
tERK Total ERK 
TGFβ Transforming growth factor beta 
x 
Abstract 
 
Hearing loss treatments have improved significantly with the advent of cochlear 
implants and advancement of hearing aids.  Still, they fall short of full restoration of 
function and do not benefit severe cases.  An ideal approach to hearing restoration 
would be replacement of hair cells as loss or dysfunction of these cells is a major cause 
of sensorineural deafness.  Therefore, recent efforts have focused on differentiation of 
pluripotent embryonic stem cells toward hair cell fate.  A relatively novel 3-dimensional 
organoid method of differentiation has produced results remarkably similar to native hair 
cells in form and function.  However, several challenges remain: Organoid hair cells are 
immature, vestibular instead of auditory, and low in yield, limiting practical use in the 
clinic or in the lab. 
Our goal was to advance the current state of hair cell regeneration efforts 
through effective adaptation of developmental signaling cues.  In these studies, we 
investigated parallels between early embryonic inner ear development and derivation of 
inner ear organoids using cell and molecular biology techniques.  Specific experimental 
questions include the following: 
 
1. Do inner ear organoids recapitulate mechanisms downstream of fibroblast growth 
factors (FGFs) involved in embryonic otic induction, establishing progenitors with 
inner ear fate? 
xi 
2. Are outcomes dependent upon transforming growth factor beta (TGFβ) inhibition 
used to recapitulate embryonic germ layer patterning? 
3. How closely do derived otic vesicles mimic native embryonic vesicles at the 
transcriptome level? 
 
A fluorescent reporter cell line was used to track differentiation through Pax2 
upregulation at the crucial otic induction stage.  The results established the utility of this 
reporter cell line and revealed key parallels with embryogenesis and opportunities for 
advancing the organoid technology.  In a follow-up study, the first differentiation step 
directing stem cells toward an inner ear lineage—inhibition of TGFβ signaling—was 
modified.  The results demonstrated that this step was dispensable for formation of otic 
progenitors but necessary for later maturation into organoid epithelia.  We performed 
comparative transcriptome analysis of stem cell-derived otic vesicles treated 
differentially at this stage and embryonic otic vesicles.  From our analysis, targets for 
further optimization efforts emerged, including retinoic acid signaling and several key 
otic genes. 
Elucidating parallels between organoid differentiation and embryonic 
development will contribute knowledge necessary to scale organoid production for 
practical use.  In the future, this work may provide suitable models of inner ear 
development, physiology, and disease for laboratory study and provide replacement 
cells for clinical treatment. 
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CHAPTER 1:  Introduction 
 
 
Hearing and balance are major components of how we perceive and interact with 
the world.  Though unique, both sensory modalities arise in the inner ear through a 
common mechanism: A mechanical event is transduced by highly specialized sensory 
cells into a neural representation interpreted by the brain.  The sensorineural elements 
of the inner ear—sensory hair cells and their associated neurons—are intricate and 
fragile.  Genetic aberrations are responsible for up to 80% of congenital deafness [1].  In 
addition, myriad insults including physical trauma, disease, drug toxicity, and aging can 
impact hearing and balance.  As a result, deficits are widespread.  Nearly 360 million 
people worldwide are living with hearing loss [2].  In the United States alone, 15% of 
adults age 18 and older report difficulty hearing, and 35% age 40 and older exhibit 
vestibular dysfunction [3,4].  The impacts include learning ability, social engagement, 
safety, and economic stability.  Because hair cells and neurons are limited in their 
potential for spontaneous regeneration, the effects of their loss or severe damage are 
permanent.  Therefore, the need to regenerate these cells by adapting knowledge of 
embryonic development toward new stem cell replacement strategies is a major goal of 
auditory and vestibular research and the focus of this dissertation. 
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STRUCTURE AND FUNCTION OF THE INNER EAR 
The ear is responsible for the early stages of auditory and vestibular processing.  
Hearing begins when high-frequency 
pressure oscillations move through all 
three major divisions of the ear (Figure 1A, 
[5]).  In brief, sound waves enter the outer 
ear and agitate the ossicles of the middle 
ear, which causes vibration of membranes 
in the inner ear.  Vestibular input—angular 
or linear acceleration of the head—
stimulates one of five balance organs of 
the inner ear, the two otolith organs 
(saccule and utricle) and the three 
semicircular canals.  In the auditory and in 
vestibular organs, mechanical forces 
stimulate sensory hair cells to send 
information via primary afferent neurons of 
the 8th cranial nerve (Figure 1B-C, [5]).        
Therefore, hair cells are the 
sensory receptors of the inner ear 
responsible for hearing and balance.  
Through the deflection of bundled hair-like 
projections called stereocilia on their apical 
Figure 1: Anatomy of the ear 
Figure from a book chapter in 
preparation [5].  A: Schematic of the 
outer, middle, and inner ear (left to 
right).  B: General structure of the 
vestibular sensory epithelia.  C: 
Arrangement of hair cells and neurons 
within the organ of Corti. 
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ends, hair cells transduce mechanical stimuli into electrical signals interpreted by the 
brain.  This process begins with depolarization and repolarization of hair cells through 
the opening of ion channels, which triggers release of synaptic vesicles from their basal 
ends onto auditory and vestibular neurons.  Consequently, hair cells themselves can be 
considered highly specialized neurons.  In addition to sharing basic mechanistic 
features, hair cells and inner ear primary afferent neurons share an ectodermal germ 
layer origin and arise from the same primordial tissue, the otic placode. 
The cochlea is the auditory portion of the inner ear.  It houses the organ of Corti 
(Figure 1C), which is the sensory epithelium comprising hair cells and supporting cells.  
These anatomical structures have a unique spiral shape following the coiled bony 
labyrinth of the cochlea.  Frequency sensitivity is distributed along the longitudinal axis 
of the cochlea in a frequency-place, or tonotopic, code, with low-frequency sounds 
processed towards the apex of the spiral and high-frequency sounds towards the base.  
In addition to this longitudinal organization, the organ of Corti is arranged laterally into 
rows of hair cells and supporting cells.  Towards the outside of the spiral are three rows 
of outer hair cells, and towards the interior is a single row of inner hair cells.  The 
precise organization of cells is established in development: Hair cells differentiate 
directionally from the mid-base of the cochlea and from inner to outer rows [6,7].  The 
center axis of the cochlear spiral is called the modiolus, and it serves as a conduit for 
neuronal processes that innervate the hair cells.  Inner hair cells are primarily 
responsible for sending signals to the brain as they receive 90-95% of afferent 
innervation [8,9].  Outer hair cells primarily receive efferent inputs, yet they account for 
up to 40-50 dB SPL of sound amplification [8,10]. 
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The vestibular portion of the inner ear is dorsal to the cochlea.  At its most dorsal 
aspect are 3 fluid-filled semicircular canals with associated chambers (ampullae) 
containing sensory epithelia (cristae).  Between the canals and the cochlea are 2 
additional vestibular chambers called the utricle and saccule, which contain their own 
sensory epithelia (maculae) (Figure 1B).  The vestibular hair cells respond to 
differences in movement between the endolymph and a gelatinous matrix surrounding 
the apical hair-like bundles; thus, they are sensitive to acceleration [11].  Vestibular hair 
cells are of two types.  Type I hair cells are characteristically flask-shaped, each with a 
single afferent calyx nerve terminal [12].  Efferent projections terminate on the calyx 
rather than directly on the hair cell [13].  Type II hair cells are cylindrical, and each 
receives multiple nerve terminals, both afferent and efferent [12,13]. 
Several features of hair cell epithelia can be considered characteristic markers.  
For instance, the apical stereocilia bundles for which hair cells are named are key to 
their mechanosensitivity.  The stereocilia are composed of actin and are thus more 
similar to microvilli than to true, tubulin-based cilia [14].  Nascent hair cells express an 
unconventional myosin, Myosin 7a (Myo7a), found almost exclusively in epithelial cells 
with microvilli or cilia.  Its expression begins in the otic vesicle at embryonic day 9 (E9) 
in mice and persists through adulthood in both cochlear and vestibular portions of the 
inner ear [15,16].  A genetic defect in Myo7a results in deafness and impaired balance 
in shaker-1 mice [17].  In humans, defective MYO7A is the underlying cause of Usher 
syndrome type IB [18].  At the base of the stereocilia in vestibular maculae is a network 
of thick filamentous actin (F-actin) bands formed by neighboring supporting cells.  This 
network of F-actin thickens over time, perhaps underlying the reduction in regenerative 
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potential of vestibular sensory epithelia observed in mice after birth [19,20].  Finally, the 
presynaptic ribbon synapse is specialized for tethering large numbers of synaptic 
vesicles; this allows sound and acceleration stimuli to be rapidly and reliably transduced 
[21–23]. 
With specialized form and unique function, hair cells are a precious resource in 
life and in the lab.  A single human cochlea contains only 3500 inner and 12000 outer 
hair cells [24].  A mouse cochlea, by comparison, has only 750 inner and 2500 outer 
hair cells [25].  These cells are well-protected by the temporal bone; however, insults to 
inner ear physiology including noise exposure, disease, toxins, aging, and genetic 
aberrations can all cause permanent impairment of hearing and balance.  The scarcity 
and inaccessibility of hair cells presents a major challenge for inner ear research and 
medicine.  The following section presents the case for a stem cell-based approach to 
hair cell regeneration with a focus on restoration of hearing. 
 
STEM CELL REGENERATION OF INNER EAR HAIR CELLS 
Current strategies for the treatment of deafness are palliative rather than 
restorative.  Hearing aids work by amplifying sound, so they primarily benefit patients 
who retain inner hair cell-auditory nerve assemblies with only mild hearing loss.  
Patients who do wear hearing aids may be able to detect sound but nonetheless 
struggle to perceive salient features such as a single voice in a crowded room.  In fact, 
in a study of hearing aid wearers in lab and field settings, hearing-impaired participants 
preferred significantly reduced loudness for general use than normal-hearing 
participants [26]; for a review of related studies on preferred loudness/gain, see [27].  
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Hearing aids can be prescribed according to various strategies for avoiding discomfort 
involved with excessive loudness while optimizing detection of frequencies associated 
with human speech [28].  Even so, auditory information important to speech recognition 
and other functional outcomes involves temporal processing and the ability to 
discriminate between frequencies, which are not fully addressed by hearing aids [28].  
Advancements in hearing aid technology are still accompanied by trade-offs requiring 
clinicians to address patients’ individual priorities for effectiveness.  Besides this, many 
patients avoid using hearing aids due to expense or stigma. 
Cochlear implants are a revolutionary technology for patients with severe hearing 
loss who nonetheless retain some primary auditory neurons.  Using an array of 
electrodes, the implant directly stimulates the cochlear neurons at various points along 
their tonotopic arrangement.  Therefore, the implant bypasses the hair cells, permitting 
sound detection in the absence of functional hair cells.  For this strategy to be effective, 
some cochlear neurons must be viable and responsive to the electrodes.  This is 
problematic for implant candidates because cochlear neurons may degenerate over 
time in a deafened ear [29–31].  Regardless, cochlear implants use only a few dozen 
electrodes, drastically limiting the number of discernible frequencies within the spectrum 
of normal human hearing (20 Hz to 20 kHz) [32].  Spectral resolution is only one factor 
determining the success of cochlear implants, so even for the best candidates, 
increasing the number of electrodes does not necessarily improve speech recognition 
[33].  Additionally, the poor representation of music and poor perception of speech in 
noise are often-cited shortcomings of cochlear implants [32,34].  Addressing these 
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remaining challenges may necessitate the combination of cochlear implants with 
biological therapies. 
An ideal strategy to restore hearing would address the root cause of 
sensorineural deafness by repopulating of the deafened auditory epithelium with hair 
cells.  Hair cell regeneration occurs spontaneously in non-mammalian species including 
cold-blooded species and birds [35–38].  In general, spontaneous regeneration in adult 
mammals occurs only in the utricle, to a limited extent, through asymmetric division or 
direct transdifferentiation of supporting cells [39–41].  Recent evidence shows that a 
small percentage of supporting cells in the early postnatal mammalian cochlea can 
regenerate hair cells [42–46].  The Wnt target genes Lgr5 and Axin2 are proposed 
markers for supporting cells with regenerative potential, so-called inner ear stem cells 
[46–51].  Extensive further investigation will be necessary to harness this potential for 
therapeutic benefit [52].  In development, hair cells and supporting cells diverge from 
common prosensory precursors through Notch-mediated lateral inhibition [53]: Ligand 
expression on the surface of one cell activates the Notch receptor on an adjacent cell, 
triggering downregulation of the hair cell-specifying gene Atoh1 [54].  As a result, the 
former becomes a hair cell and the latter a supporting cell.  Inhibition of Notch signaling 
has been shown to promote hair cell transdifferentiation from supporting cells in early 
postnatal mouse cochleae [46,55,56].  However, the ability to respond to Notch 
inhibition decreases as Notch pathway components are downregulated with age [55].  
Regardless, transdifferentiation is not ideal since it reduces the population of supporting 
cells, which are important components of sensory epithelia.  Supporting cells may not 
be available for transdifferentiation to occur at all in cases of profound deafness in 
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which the organ of Corti has been reduced to a flat epithelium [57].  Without a ready 
source of endogenous stem cells in the mature cochlea, embryonic or induced 
pluripotent stem cells are a logical alternative to provide hair cells or hair cell precursors 
for transplantation into deafened epithelia. 
Guided differentiation of stem cells towards hair cell fate has the potential to 
revolutionize the study and treatment of hearing and balance disorders.  To date, 
several approaches to produce hair cells have been published (Table 1).  They begin 
with aggregation of stem cells into spheres, or embryoid bodies, which initiates 
differentiation.  From there, they diverge based on whether differentiation proceeds 
within a 2-dimensional (2D) or 3-dimensional (3D) culture.  The 2-dimensional approach 
involves allowing the embryoid bodies to attach to a flat substrate.  The substrate may 
be seeded with feeder cells to supply growth factors, or growth factors and small 
molecule morphogens may be supplied in liquid media.  Ultimately, the adherent cells 
are screened for hair cell markers to assess differentiation.  A 2-dimensional approach 
is attractive due to the increased level of control over the cells’ environment.  The 
physical properties of a substrate can be determined, for instance, by choosing 
materials with more or less tension or materials that bind to cells through different 
mechanisms.  Also, control over the influence exerted by supplied morphogens is 
optimal in monolayer cultures since the medium has direct access to all cells.  The 
simplicity of this approach is, however, also a major limitation given that the embryonic 
environment in which hair cells form is far more complicated.  Supplying exogenous 
morphogens at appropriate doses and timing is only one piece of the complex puzzle of 
modeling development in vitro. 
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Table 1: Basic strategies and outcomes of stem cell protocols for hair cell production 
 Stem cell 
type 
Initiation Terminal 
differentiation 
Indication of best average efficiency achieved 
Li et al. 2003 
[58] 
Mouse 
ESCs* 
3D 2D ~5% Atoh1+/Brn3.1+ 
~5% Atoh1+/Myo7a+ 
(immunostaining) 
Oshima et al. 
2010 [59] 
Mouse 
ESCs and 
iPSCs** 
3D 2D 0.36 ± 0.07% Atoh1+/Myo7a+/Espin+ 
(immunostaining) 
Chen et al. 
2012 [60] 
Mouse 
ESCs 
3D 2D <1% of otic epithelial progenitors develop 
apical projections and express espin (SEM 
and immunostaining) 
Ouji et al. 
2012 [61] 
Mouse 
ESCs 
3D 2D 17.2 ± 2.1% Atoh1+/Brn3c+ 
26. 3 ±1.3%, Atoh1+/Myo6+ 
16.1 ± 2.4% Atoh1+/calretinin+ 
(immunostaining) 
Ouji et al. 
2013 [62] 
Mouse 
ESCs 
3D 2D 12.8 ± 1.2% Myo6+ 
9.8 ± 1.3% Brn3c+ 
8.9 ± 0.8% α9AchR+ 
(immunostaining) 
Ronaghi et 
al. 2014 [63] 
Human 
ESCs 
3D 2D ≤9.03% of cells positive for 3 or more hair cell 
markers 
(single cell RT-PCR) 
Ohnishi et al. 
2015 [64] 
Human 
iPSCs 
2D 2D 0.01 ± 0.008% Myo7a+ 
(immunostaining) 
Ding et al. 
2016 [65] 
Human 
ESCs 
2D 2D 5.8% Espin+ feeder-free or 6.7% on chicken 
utricle stromal feeder cells 
(immunostaining)  
Kil et al. 
2016 [66] 
Human 
MSCs*** 
2D 2D N/A 
Ouji et al. 
2017 [67] 
Mouse 
ESCs 
3D 2D 28.4 ± 4.7% Brn3c; 36.3 ± 6.1% Myo6 
(immunostaining) 
Koehler et al. 
2013 / 
Koehler et al. 
2014 [68,69] 
Mouse 
ESCs 
3D 3D 10-20% of aggregates with organoid(s) at day 
20 
1552.3 ± 83.1 Myo7a+ cells per aggregate at 
day 20 (starting from 3000 cells/aggregate at 
day 0) 
(immunostaining) 
DeJonge et 
al. 2016 
(modification 
of Koehler et 
al. 2013) [70] 
Mouse 
ESCs and 
iPSCs 
3D 3D ~60% of aggregates with organoid(s) at day 
20 
Koehler et al. 
2017 [71] 
Human 
ESCs and 
iPSCs 
3D 3D 19.7 ± 7.0% of aggregates with organoid(s) at 
days 60-100; 68-779 hair cells per organoid 
(average 226; 12 organoids assayed) 
McLean et 
al. 2017 [51] 
Lgr5+ 
supporting 
cells 
In vivo 3D 26.3% ± 2.5% of cells Atoh1+ 
 
 
* ESCs = Embryonic stem cells 
**iPSCs = Induced pluripotent stem cells 
***MSCs = Mesenchymal stem cells 
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A novel hair cell regeneration method, the inner ear organoid protocol, using 3-
dimensional cultures was published in 2013 [68].  It was developed on the foundation of 
central nervous system (CNS) and optic organoid studies using “serum-free floating 
culture of embryoid body-like aggregates with quick reaggregation,” or SFEBq [72,73].  
With this method, 3-dimensional stem cell aggregates are guided through an initial 
ectodermal differentiation phase recapitulating early stages of embryonic development.  
Then, in the final maturation phase, the aggregates self-pattern with minimal input of 
exogenous factors.  The earlier phase establishes tissue layers mimicking the 
embryonic germ layers ectoderm, endoderm, and mesoderm.  As the intact aggregates 
continue to mature, the various cell types in these layers will exert influences on each 
other through contact cues and secreted factors.  During the first half of the maturation 
phase, the epithelial ectodermal layer pinches off into the surrounding mesendodermal 
tissue to form vesicles.  This process is analogous to the formation of the otic vesicle, 
the anlage of the inner ear, through invagination of the otic placode at E9-9.5 in mice.  
In the second half of maturation, the vesicle expands in size, resulting in a cyst lined 
with hair cells, with the apical side facing the lumen of the cyst as in the sensory 
epithelia of the inner ear.  Therefore, 3-dimensional differentiation culture takes 
advantage of physical and chemical properties inherent in a heterogeneous aggregate, 
much like unique tissue types develop in context of a whole embryo.  Heterogeneity is 
currently the limiting factor in terms of yield; however, steps have already been taken to 
begin optimizing the protocol to maximize production of otic tissue [70,74]. 
High-throughput, high-yield methods are essential to the goals of stem cell-based 
inner ear research.  Understanding genetic causes of deafness and balance disorders, 
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discovering otoprotective drugs, studying hair cell physiology, and modeling auditory 
and vestibular development would all be facilitated by a sustainable source of hair cells.  
The results of initial experiments with the inner ear organoid protocol show its potential 
to become a powerful tool in a variety of applications.  Aspects of the protocol that need 
further optimization include throughput and yield as well as reproducibility, functional 
maturation of hair cells, and control over hair cell type.  Incorporating additional aspects 
of developmental biology may improve the protocol; in parallel, studying organoid 
differentiation may inform developmental studies.  Through this reciprocal exchange of 
ideas, the inner ear organoid protocol be developed as a means of generating new hair 
cells to restore hearing and balance. 
 
TAKING CUES FROM THE MAMMALIAN EMBRYONIC INNER EAR 
Embryonic development is a profoundly complex biological process.  The 
influences of secreted morphogens, contact cues, physical reorganization, and the 
extraembryonic milieu are spontaneously orchestrated so that a whole organism is born 
of a single zygote cell.  Just as the relative levels and timing of various instruments are 
conducted in an orchestra, so too are the levels and timing of processes regulated in 
development.  Dividing an entire composition into movements—or an entire 
developmental program into phases—is useful for its conceptualization. 
The inner ear organoid protocol for stem cell differentiation is divided into two 
phases, as described in the previous section: ectodermal differentiation and maturation 
(Figure 2).  Within the ectodermal differentiation phase are two applications of small 
molecules and growth factors.  First, an inhibitor to the TGFβ pathway and bone 
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morphogenetic protein 4 (BMP4) are added at day 3.  Second, a BMP pathway inhibitor 
and fibroblast growth factor 2 (FGF2) are added between day 4-4.5, with the timing 
optimized for the specific stem cell line used.  Each addition recapitulates distinct events 
between germ layer formation in the gastrula-stage mouse embryo (~E6.5) and 
induction of otic progenitors (~E8.5) (Table 2). 
 
Early TGFβ inhibition favors ectodermal lineage by inhibiting formation of 
mesoderm and endoderm 
The addition of a TGFβ pathway inhibitor on day 3 of the organoid protocol is 
based on the mechanism of ectodermal differentiation in the embryo.  As the first step 
along an otic lineage, its efficiency is crucial to the ultimate production of hair cells in the 
organoids; each step in the organoid protocol establishes competence to respond to the 
next pro-otic cue.  Therefore, understanding how TGFβ signaling is regulated in early 
embryonic patterning will ensure that the strategy used to manipulate this pathway in 
vitro is purposeful and effective. 
Figure 2: General schematic of organoid differentiation 
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Table 2: Developmental stages recapitulated in inner ear organoid protocol 
 
In the developing mouse embryo, TGFβ signaling plays a major role in 
establishing the anterior-posterior body axis (reviewed in [76,77]).  This process is 
initiated just prior to gastrulation, a major rearrangement of epiblast that results in 
specification of the 3 germ layers that are precursors to all tissues of the body.  Anterior-
posterior patterning begins when distal visceral endoderm (DVE) shifts asymmetrically 
to form an anterior pole at E5.5 [76].  By E6.5, it has finished shifting and is redefined as 
anterior visceral endoderm (AVE) [76].  At this point, gastrulation begins with the 
formation of the primitive streak, an elongated groove through which epiblast tissue 
migrates to form layers of endoderm and mesoderm within the embryo.  The anterior-
most epiblast tissue that does not migrate through the primitive streak loses 
Developmental 
stage 
Transition 
mediated 
Embryonic 
day (mouse) 
Embryonic 
mechanism 
Inner ear 
organoid day 
Inner ear 
organoid cue 
Germ layer 
specification 
Presumptive 
ectoderm  
Definitive 
ectoderm 
E6.5 - 7 TGFβ 
inhibition 
3 SB431542 
[68] 
Divergence of 
neural and non-
neural ectoderm 
Definitive 
ectoderm  
Non-neural 
(surface) 
ectoderm 
E7 - 7.5 BMP4 3 rhBMP4 [68] 
Specification of 
preplacode and 
epidermis 
Non-neural 
ectoderm  
Preplacodal 
ectoderm 
E7.5 - 8 BMP 
inhibition 
4-4.5 LDN193189 
[68] 
Otic induction Preplacodal 
ectoderm  
Otic placode 
E8 - 8.5 FGF3/10 4-4.5 rhFGF2 
[68,70] 
Otic prosensory 
domain 
specification 
Otic placode 
 Prosensory 
domain 
E8.5-E12.5 Wnt 8-14 CHIR99021 
[70] 
Hair cell 
differentiation 
Prosensory 
domain  
sensory hair 
cells 
E12.5 
(vestibular) 
or E14.5 
(auditory) 
Lateral 
inhibition 
14-20 Note: 
Atoh1 is 
upregulated 
as early as 
day 12 [75]. 
Self-directed 
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pluripotency and specifies as definitive ectoderm [77].  This gives rise to neuroectoderm 
and to non-neural ectoderm, from which the inner ear derives, in a subsequent 
specification involving BMP signaling. 
The effect of TGFβ signaling in gastrulation is to promote endoderm and 
mesoderm (reviewed in [78]).  Accordingly, endogenous antagonists of TGFβ signaling 
promote ectoderm.  
TGFβ is one of a 
family of related 
ligands that also 
includes Activin and 
Nodal (Figure 3 and 
Table 3).  Nodal 
expression is initially 
ubiquitous throughout 
the epiblast but becomes restricted towards the posterior pole during formation of the 
anterior-posterior axis [79].  The AVE secretes antagonists to Nodal, protecting the 
definitive ectoderm from its posteriorizing influence [80–84].  In mouse loss-of-function 
mutants for Nodal, the primitive streak and AVE do not form [80,85–88], which may 
result in premature differentiation and expansion of neural ectoderm [88].  Similarly, in 
vitro culture of anterior epiblast explanted prior to ectodermal commitment in the 
presence of SB431542—the same TGFβ signaling inhibitor used in the inner ear 
organoid protocol—results in upregulation of neural markers [89].  If these explants are  
Figure 3: Simplified TGFΒ signaling pathway 
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Table 3: Components and regulators of TGFβ superfamily signaling pathways 
 TGFβ BMP 
Type I receptors ALK4/5/7 ALK2, 3, and 6 
Type II receptors ActRII/IIB and TβRII ActRII/IIB and BMPRII 
Ligands (and their 
receptors) [90] 
Activin (ALK4/5 and ActRII/IIB) 
Nodal (ALK4/7 and ActRII/IIB) 
TGFβ (ALK5 and TβRII) 
BMPs (ALK2/3/6 and 
ActRII/ActRIIB/BMPRII) 
Effectors Smad2 and Smad3 Smad1, 5, and 8 
Commonly-used 
inhibitors (and 
their targets) 
LeftyA (Smad2), RepSox (ALK5), 
SB431542 (ALK4/5/7), SIS3 
(Smad3) 
Chordin (BMP2/4), Dorsomorphin 
(ALK2/3/6), Noggin (BMP2/4), 
LDN193189 (ALK2/3/6) 
 
also cultured in the presence of BMP4, non-neural ectodermal markers are upregulated 
[89].  Conversely, Activin has been used in place of Nodal to induce mesoderm and 
endoderm in stem cell cultures [91–94].  However, its role in this process in embryonic 
development may not be conserved in mammalian species [94,95]. 
Given this evidence of the role of Nodal in development, TGFβ inhibitors have 
been adopted as efficient inducers of ectodermal lineage in stem cell differentiation 
protocols.  SB431542 promotes neuroectoderm in cultures of mouse epiblast stem cells 
(EpiSCs) or human embryonic stem cells (hESCs) [96–98].  A protocol for 
telencephalon organoids that was a precursor to the SFEBq approach used LeftyA to  
inhibit Nodal and thereby promote neural specification [99].  BMP signaling, like TGFβ 
signaling, favors non-ectodermal germ fate during early patterning of the mouse embryo 
[100].  BMP4 expressed within extraembryonic tissue plays a role in reinforcing Nodal 
within the posterior epiblast, thereby maintaining the AVE [78,101].  Because TGFβ and 
BMP pathways are primary regulators of ectoderm specification, a dual inhibition 
strategy targeting both pathways (called dual-Smad-inhibition after the canonical 
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downstream effectors) has been used in vitro to derive CNS neurons from stem cell 
cultures [102]. 
SB431542 is also used as the pro-ectodermal morphogen for differentiation of 
inner ear organoids.  The ectodermal lineage path toward CNS neurons diverges from 
the path toward inner ear fate, however, with the specification of neural and non-neural 
progenitors.  BMP signaling is key to navigating this change in lineage paths in 
development; therefore, BMP4 is paired with SB431542 at day 3 of organoid 
differentiation. 
 
Role of BMP4 in inhibiting default neural ectodermal fate, promoting non-neural 
ectoderm 
Concomitant with its role in patterning the anterior-posterior axis, BMP4 is 
involved in patterning neural and non-neural fates along the dorsal-ventral axis.  Prior to 
gastrulation, BMP4 secreted from surrounding tissue counteracts the tendency of 
anterior ectoderm to become neural [103,104].  This tendency toward neural fate in the 
absence (or rather antagonism) of BMP signaling is referred to as the “default model” of 
neural induction (reviewed in [105–107]).  The importance of pre-gastrula BMP inhibition 
for anterior neural ectoderm in mammals was first shown in mice lacking the 
endogenous BMP antagonists Chordin and Noggin (Table 3) [108].  Forebrain tissue is 
severely lacking in the double mutants but is not completely absent.  This suggests that 
inhibition of the BMP pathway is not solely responsible for neural induction [108,109].  
Indeed, FGF and Wnt signaling are also implicated. 
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Of the 3 BMP type 1 receptors, BMPR1a (or ALK3) is the only one expressed in 
the epiblast [110,111].  Mice lacking BMPR1a show premature neural markers, 
expansion of neural tissue, and reduction of non-neural ectoderm [104,112].  This 
phenotype is similar to the Nodal knockout phenotype [88], which may be evidence of 
the role BMP4 plays in reinforcing Nodal expression as described in the previous 
section.  The default model of neural induction was first established through studies of 
Xenopus and zebrafish; loss of non-neural ectoderm in BMPR1a-deficient mice 
provides support for it in a mammalian system.   
Definitive ectoderm has the potential to become neural or non-neural depending 
on exposure to BMP4 [105].  It represents an intermediate stage between ectodermal 
commitment and differentiation of neural or non-neural derivatives.  Though this 
developmental stage had long been established in non-mammalian vertebrates [105], it 
was only relatively recently demonstrated in a mammalian models.  In 2013, a mouse 
study identified definitive ectoderm and highlighted its transient nature with anterior 
ectoderm explants prepared at E6.5, 7.0, or 7.5 [89].  In the presence of BMP4, the 
E6.5 explants were redirected toward mesoderm and endoderm fate, but this 
pluripotency was lost by E7.0.  The E7.0 explants could be directed toward neural or 
non-neural fate depending on absence or presence of BMP4 but had committed to one 
or the other fate by E7.5.  A similar experiment demonstrated a transient population of 
cells analogous to definitive ectoderm in mouse embryonic stem cells (mESCs) cultured 
under a neural induction paradigm with conditioned medium [113]. 
Other neural induction protocols use defined culture media components to 
differentiate stem cells.  As mentioned, BMP signaling both reinforces TGFβ signaling in 
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germ layer specification and functions separately in regulating neural fate.  Some 
studies have reported necessity of either BMP inhibition or TGFβ inhibition for inducing 
neural fate.  For instance, Surmacz et al. first recognized the utility of the small molecule 
LDN193189 as an alternative to the animal-derived BMP inhibitors Noggin and 
Dorsomorphin [114].  Paired with SB431542, it was effective at upregulating Pax6, used 
in the study as a marker of neural fate, in their hESC differentiation paradigm.  
However, neither LDN193189 nor SB431542 was an effective neural inducer by itself.  
Surmacz et al. note that this contrasts with results from other groups showing that 
Dorsomorphin alone or SB431542 alone was an effective inducer of neural fate from 
hESCs [97,98,114,115].  Reconciling these differences, Kim et al. showed that stem cell 
lines of various origins have differential basal levels of activated Smad1/5/8 [116].  This 
explains differential requirements for BMP inhibition.  Furthermore, they established that 
dual inhibition—using Dorsomorphin and SB431542 together in their study—was able to 
overcome inherent cell line differences for effective neural induction [116]. 
 
Two-step commitment to preplacodal fate: Elevation and subsequent attenuation 
of BMP signaling at the border between neural and non-neural tissues 
The signals involved in segregating neural vs non-neural ectoderm precursors 
are then involved in medial-lateral patterning of neural plate, neural crest, preplacodal 
ectoderm (PPE), and epidermis [117,118].  BMP4 is elevated towards the lateral 
ectoderm where it promotes epidermis [118].  In non-mammalian species, FGF8 is 
implicated in counteracting BMP4 in medial ectoderm through phosphorylation of the 
Smad1 effector [119], thereby reinforcing neural fate choice [120].  Evidence suggests a 
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similar pro-neural capacity for FGF in mammals but is not conclusive as to whether the 
mechanism is direct through Smad1 regulation [121,122] or independent of BMP 
signaling [123,124].  Wnt signaling is also implicated in patterning neural and non-neural 
tissue.  In chicken embryogenesis, Wnt expressed in lateral ectoderm blocks FGF-
mediated antagonism of BMP4 and thereby permits non-neural fate1 [128].  The 
integration of these signals results in neural crest and PPE.  Although neural crest and 
PPE arise from a common “neural border region” between the future neural plate and 
epidermis, competence to become one or the other segregates with specification of 
neural vs non-neural lineages prior to patterning [129].  
Towards the end of gastrulation, antagonism of BMP signaling mediates a 
refinement of non-neural (i.e., surface) ectodermal fate (Figure 4) [130].  Persistent 
BMP signaling results in epidermis from more ventral/lateral ectoderm, whereas 
complete attenuation results in PPE in the immediately adjacent border region [130].  
PPE gives rise to the various cranial placodes, thickened regions of ectoderm that 
differentiate into cranial nerves and specialized sensory cells including those of the 
inner ear.  As PPE-specific genes (e.g., Eya1/2 and Six1/4) are upregulated, they 
positively auto-regulate so that PPE tissue is committed to its fate and its boundary with 
neural crest is refined [118]. 
Development of PPE has been recapitulated in embryonic stem cell cultures.  
Two protocols building on the dual-Smad-inhibition approach using SB431542 and 
Noggin to derive CNS neurons from hESCs were published in 2013 [131,132].  In one 
                                            
1 Wnt has been reported to block or promote neurogenesis in conflicting reports from non-mammalian 
studies (reviewed by [125]).  However, the two models resulting from these conflicting reports may be 
reconciled by differences in the roles of Wnt at different developmental stages [126,127]. 
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protocol, both inhibitors were removed on day 3, and preplacodal markers were 
observed on day 8 [131].  This report noted that endogenous BMP was necessary 
between days 3 and 5.  In the other, only Noggin was removed on day 3, leaving only 
SB431542 in the media, to shift the fate from neural to preplacodal by day 11 through 
increased BMP signaling [132].  Both protocols resulted in a transient PPE stage that 
could be pushed to a specific placodal fate through additional exogenous factors.  
Another protocol parted from the dual-Smad-inhibition approach, pairing SB431542 with 
a Wnt inhibitor instead of Noggin, and observed PPE markers after 6 days [133].  After 
a series of additional factors applied together with FGF2, markers of otic placode were 
induced.  Additional protocols for producing CNS neurons [134,135] as well as neural 
crest [136,137] and epidermis [138–141] from human or mouse ESCs have been 
published.  Exact mechanisms leading from BMP, Wnt, and FGF signaling to PPE 
commitment are unclear, and much evidence supporting current models of PPE 
development is from non-mammalian research.  However, the models presented by 
Groves and LaBonne attempt to reach consensus in the existing evidence across 
species [118].  Kwon et al. provide a concise model summarizing the proposed 
modifications to the original default model of neural induction and how the PPE lineage 
diverges from the neural, neural crest, and epidermal lineages in development (Figure 
4) [130].  The model lays out a 2-step process in which BMP4 is initially required for 
non-neural ectoderm, and its complete attenuation is subsequently required for 
preplacode.  In the inner ear organoid protocol, this stepwise transition is performed 
through initial application of BMP4 at day 3 and inhibition via LDN193189 24-36 hours 
later.  
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FGF2 recapitulates the otic induction stage of development, when inner ear 
progenitors commit to otic fate 
The next step in the inner ear organoid protocol is application of FGF2 at day 4.5.  
This is analogous to the upregulation of FGFs in tissues neighboring the presumptive 
otic ectoderm shortly after gastrulation.  Around E8 in mice, FGF10 is upregulated in 
mesenchyme [142,143].  Shortly thereafter, FGF3 is upregulated in rhombomeres 4-6 of 
the hindbrain [142,143].  By E8.75, the expression pattern of FGF10 has already shifted 
so that FGF10 is found less in mesenchyme and more in the adjacent hindbrain [143].  
FGF3 remains in rhombomeres 5-6 through E9.5, when the inner ear begins to take 
shape with formation of the otic vesicles [144]. 
The onset of FGF3 and FGF10 drives expression of the transcription factor Pax2 
by E8.5, just after expression of Pax8 [143,145].  This event is generally considered 
Figure 4: Spatiotemporal inhibition of BMP4 in patterning neural and non-neural 
ectoderm 
Figure redrawn from Kwon et al. 2010 [130].  In the late blastula stage of development (left), 
the domain that gives rise to PPE (and neural crest, NC) is characterized by an intermediate 
level of BMP signaling.  By the late gastrula stage (right), attenuation of BMP signaling 
results in PPE specification. 
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definitive of otic induction, or commitment to inner ear fate.  Pax2 and Pax8 are closely-
related genes [146] necessary for normal development of the inner ear [147–150].  
Pax2 can largely compensate for Pax8, but Pax8 cannot completely compensate for 
Pax2 [150].  This may be explained by differences in timing since Pax8 expression only 
persists through early otic vesicle formation [151], whereas Pax2 is maintained in the 
ear through at least the first week postnatal [149,152]. 
Several studies have examined the necessity of FGF3 and FGF10 in inner ear 
development through characterization of mutant mouse strains [142,143,153–155].  The 
loss of FGF32 is more disruptive to otic vesicle formation and patterning than loss of 
FGF10 when assessed at E9.5: Vesicles are smaller, are positioned more ventrally, and 
show a dorsal-lateral shift in Pax2 from its normal ventromedial domain [143].  In 
addition, formation of the endolymphatic duct and cochleovestibular ganglion (cvg) is 
inhibited in FGF3 null mice [153,155], and expression of various dorsal otic vesicle 
markers is affected with regards to level or domain [155].  Mice null for both FGF3 and 
FGF10 form very small vesicles or no vesicles at all [142,143,156].  Furthermore, otic 
markers Pax2, Pax8, Gbx2, and Dlx5 are either severely reduced or lost from the 
placode [142,143].  These studies highlight the crucial role of FGF signaling in induction 
of otic markers and morphological development of the inner ear. 
Another FGF ligand, FGF8, may contribute to inner ear development through its 
effect on FGF10 expression.  Combined loss of FGF3 and FGF8, which is normally 
found in the endoderm surrounding the pre-otic ectodermal field, results in a similar 
                                            
2 Alvarez et al. report the lack of a phenotype from loss of FGF3 [142].  Hatch et al. suggest that various 
mouse genetic backgrounds or mutagenic strategies may underlie discrepancy in observed FGF3 null 
phenotypes [155]. 
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phenotype to FGF3/10 double knockouts [157,158].  FGF10 expression in the 
mesenchyme adjacent to the otic field is reduced in FGF3/8 double mutant mice, 
suggesting that FGF3 and 8 may be involved in inducing or maintaining FGF10 
[158,159].  Thus, the similarity in phenotypes in FGF3/8 double mutants and FGF3/10 
double mutants may reflect overlapping functions and mutual positive regulation 
amongst these genes.  
Even after FGF3/10 induces Pax2 expression, the borders of the otic domain are 
yet unresolved.  The early otic placode is part of a larger Pax2+ region called the otic-
epibranchial progenitor domain (OEPD) [160,161].  Separation of otic and epibranchial 
placodes as well as separation of otic placode and epidermis are controlled by Wnt 
signaling.  After FGF signaling sets up the OEPD, it upregulates Wnt8a in the adjacent 
hindbrain [156,159].  Wnt signaling then bolsters expression of otic genes (Pax2, Pax8, 
Gbx2, and Sox9) and restricts epidermal and epibranchial fates [162].  β-catenin is the 
primary effector of the canonical Wnt pathway.  In a transgenic mouse, conditional 
expression of a stabilized β-catenin in Pax2+ cells results in an enlarged otic placode via 
recruitment of prospective epidermal cells [162].  This mouse also supports a 
dorsalizing role for Wnt, counterbalanced by sonic hedgehog (SHH) from the ventral 
hindbrain and notochord [163,164]: The expression domains of dorsal markers Dlx5, 
Gbx2, and Msx1 are expanded ventrally throughout the enlarged placode at E9.5, yet 
Dlx5 and Msx1 are repressed in the medial portion nearest the ventral neural tube as 
the placode invaginates [162].  Conditional deletion of Wnt results in a smaller placode 
and otic vesicle and encroachment of Foxi2+ epidermis into the normal otic field [162].  
The Notch pathway reinforces the pro-otic role of Wnt [165].  Wnt upregulates 
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components of the Notch pathway, and in return, Notch signaling leads to increased 
Pax8 and the thickening of ectoderm that marks the otic placode [165]. 
Additional refinement of placodal boundaries occurs along the anterior-posterior 
axis: Anterior placodes (lens, olfactory, and adenohypophyseal) are characterized by 
Pax6 expression, trigeminal by Pax3, and posterior placodes (otic and epibranchial) by 
Pax2.  These Pax genes repress one another and so contribute to the segregation of 
placodes.  The importance of Pax2 and 8 in otic induction is underscored by the 
characterization of Pax2 null and Pax2/8 double null mouse embryos (Table 4).  
Furthermore, 55 different mutations in PAX2 have been described in humans with renal 
coloboma syndrome, with 7% of patients exhibiting hearing loss [166].  However, even 
Pax2/8 double null mice develop an otic vesicle, although it does not develop past this 
stage [150].  This suggests that Pax2 and 8 are not master regulators initiating all 
subsequent events in inner ear development.  Although Pax2 serves as a useful marker 
of otic lineage for inner ear studies, it is expressed in other tissues in the mouse embryo 
[167–169] and should be considered one of a panel of otic markers when characterizing 
differentiating stem cells. 
The use of FGFs as otic inducers in vitro requires consideration of which ligand 
or ligands to use.  Some stem cell differentiation protocols use FGF3 and 10 to produce 
hair cells as in the embryo [60,65], but others substitute FGF2 [51,58,59,63,64,68,71].   
As ligands, FGF3 and 10 have highest affinity for the IIIb isoform of FGFR2 above 
all other FGF receptors [170,171], and FGFR2IIIb knockout mouse inner ears have a 
similar phenotype compared to FGF3 knockouts [172].  However, FGF2 activates 
various isoforms of FGF receptors with broad affinity, including the isoforms favored by  
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Table 4: Pax2 and Pax8 mutant mouse phenotypes 
Genotype Mutation Inner ear phenotype Citation 
Pax2Krd/+ Large deletion of 
chromosome 19 
Normal auditory brainstem 
response (ABR) 
Keller et al. 1994 [173] 
Pax21Neu Spontaneous 1-bp 
insert resulting in 
early stop codon, 
identified in 102 X 
C3H hybrid 
Agenesis of cochlea (E14.5) 
Degeneration of spiral ganglion 
(E14.5) 
Enlarged ventral chamber in place 
of vestibular sensory portions 
(E14.5) 
Favor et al. 1996 [147] 
Note: This is the same 
insertion/frameshift 
mutation as was described 
in a family with human renal 
coloboma syndrome [174]. 
Pax2-/- Deletion of 4kb 
including beginning 
prior to codon and 
extending through 
exon 2, 129sv 
background, 
described in Torres 
et al. 1995 [175] 
Agenesis of cochlea (E17) 
Agenesis of spiral ganglion (E13.5) 
Normal vestibular development 
(E17) 
Torres et al. 1996 [148] 
Pax2-/- Obtained mice from 
Torres et al. 1995 
[175], C57BL/6 
background 
Rudimentary cochlea (E15.5) 
Degeneration of cells normally 
expressing Pax2 in cochlea 
(E11.5) 
Degeneration of vestibular and 
spiral ganglia (E15.5) 
Distinct saccule often missing 
(E15.5) 
Note: Severity of phenotypes 
varied amongst embryos. 
Burton et al. 2004 [149] 
Pax2-/- LacZ inserted into 
Pax2, replacing 
exons 2 and 3, 
C3H/He background 
[176] 
Absence of cochlear duct (E13.5) 
Degeneration of cochlear duct and 
adjacent mesenchyme (E13.5) 
Degeneration of spiral and 
vestibular neurons (E13.5) 
Agenesis of spiral ganglion (E18.5) 
Utricle, saccule, and cochlea 
combined into enlarged sack 
(E18.5) 
Bouchard et al. 2010 [150] 
Pax8-/- Cre inserted into 
Pax8 exon 3, 
C3H/He background 
[150] 
Normal cochlea (E11.5) 
Normal spiral and vestibular 
ganglia (E13.5) 
Bouchard et al. 2010 [150] 
Note: Pax8 null mice are 
deaf due to athyroidism 
affecting synaptogenesis.  
See Christ et al. 2004 [177] 
Pax2-/-; 
Pax8-/- 
 Arrest of inner ear morphogenesis 
at otic vesicle stage (E11.5) 
Arrest of neuronal development 
(E11.5) 
Bouchard et al. 2010 [150] 
Pax2Egfp/Egfp Egfp inserted into 5’ 
regulatory sequence 
Otic vesicle observed (E11.5) 
Abnormal inner ear morphology 
observed in perinatal lethal embryo 
(Our unpublished observation) 
Soofi et al. 2012 [178] 
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FGF3 and FGF10 [170,171,179].  A study using explants of avian presumptive otic 
ectoderm showed that otic vesicles could form in vitro when attached to the adjacent 
section of hindbrain [180].  When the hindbrain was removed in this study, the ectoderm 
did not form vesicles except when FGF2 was added to the media at a high dose (200 
ng/mL).  In sum, the avian explant study highlights that an inductive cue from the 
hindbrain (i.e., FGF3) is necessary for otic vesicle formation.  It also supports the use of 
FGF2 as a substitute for FGF3 and FGF10 in the inner ear organoid protocol. 
 
SHH/Pax2 mediates cochlear duct outgrowth as Wnt/Sox2 regulates the 
prosensory domain 
After day 8 of differentiation, otic vesicle-like structures that mature into 
organoids begin to form.  Differentiation proceeds in a self-guided manner: The 
surrounding tissue presumably provides contact cues and secreted factors that help to 
differentiate and pattern the vesicles.  Yet the nature of the endogenous factors 
secreted within the stem cell-derived aggregates has not been determined.  So far, only 
one exogenous factor, a Wnt pathway agonist, has been added to the protocol to 
encourage otic vesicle formation [70]. 
At E9.0 in the mouse embryo, the otic placode invaginates, forming an 
intermediate otic cup that closes off to form an otic vesicle, or otocyst, by E9.5 [181].  At 
E10.5, the vesicle begins to elongate as dorsal vestibular structures and ventral auditory 
structures begin to take shape [181].  At the same time, neuroblasts delaminate from 
the ventral aspect, contributing to the cvg [182].  By E11.5, the cochlear duct starts to 
extend and turn simultaneously until completion of 1.5 turns by E17.5 [181].  During this 
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time, several major signaling pathways are regulating major morphological changes and 
specification of prosensory and non-prosensory cells in the inner ear, leading up to 
differentiation of Atoh1+ hair cells beginning around E12.5 in vestibular structures and 
E14.5 in the cochlea [6,183].  As mentioned, Wnt from the dorsal hindbrain and SHH 
from the ventral hindbrain and notochord drive dorsal-ventral patterning of the otic 
vesicle [163,164,184].  This mirrors the dorsal-ventral patterning mechanism well-
characterized in the neural tube [185].  In the otic vesicle, SHH promotes ventral genes 
Otx2 and Pax2 and blocks the dorsal marker and Wnt target gene Dlx5 [163].  In SHH-/- 
mice, Pax2 upregulated by FGF signaling is not maintained, and the cochlear duct, cvg, 
and vestibular sensory patches fail to form [163,186].  The effect on the cvg may be due 
to loss of SHH as a direct mitogenic cue and as a regulator of posterior Tbx1 
expression, resulting in repression of the anterior cvg specifier Neurogenin 1 [187,188].  
The overall phenotypes of SHH-/- and Pax2-/- mouse inner ears support the hypothesis 
that Pax2 plays a second role in inner ear development as an anti-apoptotic, 
proliferative factor promoting cochlear duct outgrowth [149,152,189]. 
Following otic vesicle formation and patterning, Wnt also takes on a new role as 
regulator of the Sox2+ prosensory domain [190].  In this capacity, it serves to promote 
specification, proliferation, and differentiation of hair cell progenitors.  Deleting the 
downstream effector β-catenin through tamoxifen-inducible Cre recombinase at E11.5 in 
mice results in ablation of hair cells at E14.5, whereas expressing a constitutively-active 
form of B-catenin results in supernumerary hair cells [191].  In vivo and explant 
experiments indicate that Wnt activation can re-initiate cell division in post-mitotic 
progenitors at E13.5 and increase the number of hair cells [191]. 
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Sox2 is also necessary for hair cells, supporting cells, and inner ear neurons to 
differentiate [192–194], and Wnt is required for normal expression of Sox2 in the 
developing ear [190].  In mice, Sox2 is first detected in the otic placode at E8.5 and 
preferentially marks the ventral side of the otic vesicle at E9.5 [192,195–197].  By 
E12.5, Sox2 (together with Jag1 [198] and p27Kip1 [7]) marks the prosensory domain of 
supporting cell and hair cell progenitors [199].  It becomes downregulated in hair cells 
as they differentiate from E14.5 in the cochlea and is generally restricted to supporting 
cells soon after birth [16,199].  Misexpression of Atoh1 in the mammalian embryonic 
organ of Corti can induce formation of new hair cells from nonsensory cells primarily via 
transdifferentiation [193,200–202]; however, this does not occur in Sox2 knockout 
mouse explants [203]. 
Both β-catenin and Sox2 are able to interact directly with the 3’ enhancer of 
Atoh1 [203–206].   When Sox2 is expressed at a sufficiently high level, its relationship 
with Atoh1 is mutually repressive [199,204].  Recent evidence from mouse cochlear 
explants supports the model that transient expression of Sox2 confers competence of 
prosensory cells to differentiate in response to Atoh1 [203].  Similarly, Wnt signaling at 
high or low levels may have distinct effects, promoting proliferation or differentiation, 
respectively [190].  This helps to reconcile the roles of Wnt in both proliferation and 
differentiation, which otherwise are seemingly at odds. 
The extent to which Wnt depends upon Sox2 for its effects on the prosensory 
domain—and whether this is necessarily mediated through a Notch ligand Jag1 in a 
lateral induction model [198,207–210]—remains unclear.  What is clear, however, is the 
complexity of signaling cues in inner ear development, especially at this stage when the 
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tapestry of cell types is weaving itself together.  Many other pathways are acting 
concurrently to regulate the timing of differentiation throughout the ear [184].  These 
include SHH (promoting proliferation, delaying differentiation, and regulating medial-
lateral cell patterning [187,211–215]), BMP (regulating medial-lateral cell patterning and 
prosensory competence [216,217]), Notch (regulating prosensory competence through 
proposed mechanism of lateral induction [198,207,218,219]), and FGF (first promoting 
proliferation and then differentiation [220,221]).  Through these pathways, a complicated 
set of interactions takes place both within the sensory patches and between them and 
the surrounding tissues.  The inner ear organoid protocol offers a useful framework for 
producing sensory patches in context of secreted and structural cues from other cell 
types.  Discovering the nature of these cues is goal of future research.  Continuing to 
pull apart the threads of embryonic development may also reveal a pattern of cues that 
can be replicated through artificial means, providing better control and improved yields. 
 
Hair cell markers for monitoring in vitro differentiation yields 
The developmental mechanism of hair cell differentiation from prosensory cells is 
lateral inhibition driven by Notch signaling [53].  Upregulation of Atoh1 drives expression 
of the Notch ligand Dll1, activating the Notch receptor on the surface of a neighboring 
cell, leading to its repression of Atoh1 [54].  This produces both Atoh1+ hair cells and 
Atoh1- supporting cells.  At the end of the inner ear organoid protocol, hair cells 
associated with supporting cells and neurons are evident.  The ability to distinguish 
them depends on unique fate markers.  However, definitive markers of inner and outer 
auditory hair cells, type I and type II vestibular hair cells, and the various supporting cell 
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types have been difficult to pinpoint.  Markers that seem exclusive to one population of 
cells are generally also found in another population at a different time in development.  
Sox2 is a prime example: It is expressed in all prosensory progenitors but 
downregulated in hair cells, with the exception of a subset of vestibular hair cells that 
retain Sox2 into adulthood [222].  Another example is calretinin, which has been used 
as a marker of type II vestibular hair cells produced in organoids.  Its expression is 
highly variable between P13 and adulthood and can be detected at times in each type 
of cochlear and vestibular hair cell [223]. 
Because clinical strategies to address severe deafness are currently inadequate, 
the need for a reliable means to regenerate inner hair cells is particularly acute.  
Directing differentiation towards inner hair cell fate is the focus of ongoing efforts 
through application of exogenous factors involved in otic vesicle patterning.  To 
convincingly characterize outcomes, staining for a small set of cochlea-specific and 
inner hair cell-specific markers would be ideal.  With the advent of high-throughput and 
single-cell transcriptomics techniques, comparing specific cell populations at timepoints 
throughout development is possible [224–226].  These kinds of analyses are expected 
to reveal new markers for cell types contained within inner ear organoids.  Furthermore, 
RNA sequencing (RNASeq) is allowing stem cell researchers to assess the similarity of 
organoids to native tissues, predictive of their utility for transplantation [74,227–230].  In 
these ways, the field is moving toward clinical application of stem cell technology and 
restoration of function. 
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SUMMARY OF EXPERIMENTS 
Inner ear organoids contain cells comparable to native hair cells with respect to 
several features.  These include F-actin-rich stereocilia-like bundles, Myo7a expression, 
and markers of synapses with associated neurons.  However, the derived hair cells 
appear to be immature and limited to vestibular phenotypes.  Furthermore, the yield of 
derived hair cells must be improved to permit downstream applications of the inner ear 
organoid method.  Given that the method was modeled on stages of embryonic 
development, we sought to harness developmental cues that could address these 
outstanding issues. 
The experiments described in Chapter 2 were performed with a novel embryonic 
stem cell line modified with a reporter for Pax2, which is upregulated in inner ear 
progenitors following otic induction.  We used this line to study parallels between otic 
induction during organoid formation and embryogenesis via cell and molecular biology.  
Our results supported a proposed mechanism involving ERK downstream of FGF 
receptor activation.  We anticipate that these results will lead to experiments optimizing 
ERK activation to maximize the yield of otic progenitors capable of differentiating into 
hair cells.  Additionally, our investigation yielded insight into the formation of organoid-
associated neurons, another potential focus of future investigation. 
  The experiments described in Chapter 3 were focused on the TGFβ signaling 
pathway.  We investigated the necessity of TGFβ inhibition for deriving otic progenitors 
and hair cells.  We found that inhibition was necessary for organoid-stage hair cells but 
not for vesicle-stage progenitors.  We also found evidence that the mechanism of TGFβ 
inhibition influenced the efficiency of vesicle formation.  Using RNASeq, we performed a 
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comparative transcriptomics analysis of embryonic and derived otic vesicles; derived 
tissues were prepared with and without TGFβ inhibition at the first step of directed 
differentiation.  Our analysis revealed differences between native and derived vesicles 
as well as between TGFβ-inhibited and uninhibited tissues.  TGFβ inhibition is the first 
step in directing differentiation using the inner ear organoid protocol.  Thus, 
understanding the influence of TGFβ signaling on hair cell fate has the potential to 
significantly improve outcomes. 
From both investigations, potential targets for future experiments emerged.  
Manipulating developmental pathways guided by our results may lead to increased 
yields, improved maturation, or auditory rather than vestibular phenotypes.  An overall 
discussion of the completed experiments and ongoing research in Chapter 4 describes 
how these improvements would significantly advance the hair cell regeneration efforts 
toward envisioned applications in research and medicine. 
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CHAPTER 2:  Pax2EGFP cell line illuminates key stages of development in mouse 
inner ear organoid model3 
 
INTRODUCTION 
 
Hair cells, the mechanoreceptors of the inner ear, are essential to auditory and 
vestibular function.  In mammals, hair cell loss ultimately results in permanent sensory 
deficits: Cochlear hair cells do not spontaneously regenerate after loss or damage, and 
the regenerative capacity of vestibular organs is limited [232].  The advancement of 
therapies towards functional restoration is, consequently, an urgent goal of biomedical 
research. 
 Stem cells are heralded as the key to replacing damaged tissues as well as 
modeling disease states in the laboratory.  To realize this potential, we must establish 
reliable routes from naïve pluripotency to mature cell fates.  One approach is to follow 
cues from developmental literature, supplying signaling molecules as switches guiding 
differentiation along known pathways.  During embryonic development, cochlear and 
vestibular organs and cochleovestibular neurons develop from thickened regions of 
surface ectoderm between the neural plate/crest and epidermis.  These regions, the otic 
placodes, are influenced by morphogens secreted from surrounding tissues including 
                                            
3 This chapter has been accepted for publication as an original research report [231]: Schaefer SA, AY 
Higashi, B Loomis, T Schrepfer, G Wan, G Corfas, GR Dressler and RK Duncan (In press). From otic 
induction to hair cell production: Pax2EGFP cell line illuminates key stages of development in mouse inner 
ear organoid model. Stem Cells Dev. 
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the underlying mesoderm (FGFs), neural plate (FGFs), dorsal neural tube (Wnts and 
BMPs), and ventral neural tube (SHH) (reviewed in [233]). 
Koehler et al. recently pioneered a method for generation of inner ear sensory 
epithelia using a 3-dimensional stem cell culture paradigm [68,69].  Their protocol was 
built upon methods for making retinal and cerebral organoids from aggregates of 
mESCs in serum-free culture (i.e., SFEBq) [73,234,235].  The initial SFEBq methods 
were remarkably simple, belying the complexity of the tissues they produced and 
exploiting the tendency of dissociated mESCs to default to neural fates under serum-
free conditions [107,236].  Two key modifications based on developmental mechanisms 
resulted in otic tissue:  Differentiation was guided towards non-neural ectoderm via 
regulation of TGFβ/BMP signaling pathways [88,103] and subsequently towards otic 
placode via regulation of BMP and FGF signaling [130,142,143,237]. 
During formation of the otic placode, the specialized ectoderm from which all 
inner ear structures develop, FGF signaling upregulates the transcription factor Pax2 
[143,161,238–240].  Although Pax2 is expressed in multiple embryonic tissues [167–
169], it is commonly regarded as indicative of otic lineage in hair cell regeneration 
studies [58–60,63,68].  In this study, we produced inner ear organoids using mESCs 
with a reporter for expression of Pax2.  We demonstrated the utility of such a reporter 
system in identifying vesicle formation in live cultures and the maintenance of marker 
expression through terminal hair cell differentiation.  This allowed a direct relationship to 
be established between exogenous FGF2 dose and formation of otic vesicle-like 
structures.  The dose of FGF2 also corresponded directly with ERK phosphorylation, 
suggesting that ERK mediates otic induction in this model system as in avian and 
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zebrafish embryos [241,242].  Finally, we compared neurons that arise in these 
organoids with embryonic neuroblasts and identified opportunities for future 
investigation of neurogenesis. 
Overall, we draw parallels between several features of our organoids and 
developing inner ears.  The efficiency of self-patterning in organoid cultures fluctuates, 
however, with multiple determinants in need of clarification.  Therefore, since our 
evidence supports the use of inner ear organoids as a developmental model, we 
present insights into troubleshooting in hopes of advancing the field towards achieving 
the promise of stem cell technology. 
 
MATERIALS AND METHODS 
 
Mice 
All mice were housed per institutional standards and used according to 
experimental protocols approved by the University of Michigan Institutional Animal Care 
and Use Committee. 
We used mice carrying the Pax2EGFP allele, in which enhanced green fluorescent 
protein (EGFP) coding sequence is inserted upstream of the Pax2 translational start 
site, and wild-type (WT) controls on the same genetic background [178].  Breeding 
cages with Pax2EGFP/+ mice were set up to obtain embryos of all three genotypes; 
postnatal studies were performed only with WT and Pax2EGFP/+ genotypes as the 
Pax2EGFP/EGFP genotype is perinatal lethal due to renal agenesis [178].  Genotyping was 
performed using the following primers: EGFP-F (5’-CTCGTGACCACCCTGACCTA-3’), 
 36 
EGFP-R (5’-GTCCATGCCGAGAGTGATCC-3’), WT-F (5’-
ACCGTATTACCGCCATGCAT-3’), WT-R (ACCTCTACAAATGTGGTATGGCT-3’).  
Amplification with EGFP primers results in a 525-bp PCR product, and WT result in a 
230-bp PCR product.  Presence of the 525-bp product represents the Pax2EGFP allele. 
To prepare images of marker expression at roughly equivalent developmental 
stages in comparison with differentiating mESC aggregates, timed pregnant C57BL/6 
mice at E11.5 and E15.5 were obtained from The Jackson Laboratory.  Embryos were 
collected at E11.5 and E15.5, fixed in 4% paraformaldehyde (PFA), cryoprotected with 
sucrose, and cryosectioned in OCT in transverse and parasagittal planes at 12 μm 
thickness.  Staining of cryosections was performed according to the method described 
for mESC aggregates below. 
 
Auditory brainstem response (ABR) recording 
 
Mice were anesthetized with 65-120 mg/kg ketamine and 7 mg/kg xylazine, with 
or without 2 mg/kg acepromazine, administered intraperitoneally prior to the procedure.  
Mice were then placed on a heating pad inside the recording booth.  Electrodes were 
then attached at the vertex of the head, beneath the test ear, and beneath the 
contralateral ear.  Acoustic stimuli consisting of 4 ms tone bursts with 1 ms rise and fall 
times were delivered from a speaker at 30 bursts per second via a tube placed just 
outside the ear canal.  Auditory evoked potentials were recorded at three tone 
frequencies: 8, 16, and 32 kHz.  Data were acquired using the Tucker Davis 
Technologies System III, with up to 1024 responses averaged for each stimulus.  
Recordings began at 80 dB SPL, which was sufficient to elicit a response.  Stimulus 
level was reduced systematically in 5-10 dB decrements.  The minimum level eliciting a 
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reproducible waveform was determined to be the response threshold.  The recording 
system was routinely calibrated in a closed system using a reference microphone and 
lock-in amplifier. 
  
Derivation of Pax2EGFP mouse embryonic stem cells   
 
Blastocysts were flushed from the uterine horns of Pax2EGFP/+ females 3.5 days 
after mating to Pax2EGFP/+ males.  Individual blastocysts were placed in wells of a 96-
well culture plate seeded with irradiated mouse embryonic fibroblast (MEF) feeder cells 
in DMEM (high glucose, Gibco) supplemented with 15% fetal bovine serum (FBS; 
Harlan), 0.1 mM β-mercaptoethanol (Sigma), 50 IU/mL penicillin and 50 μg/mL 
streptomycin (Gibco), 1000 U/mL leukemia inhibitory factor (LIF; Chemicon), and 12.5 
μM PD98059 (Sigma).  Inner cell mass outgrowths were trypsinized and passaged 
sequentially until mESC lines were established in 35-mm cell culture dishes.  For 
genotyping, mESCs were passaged on gelatin-coated dishes twice to eliminate feeder 
cells before being genotyped as described [178].  For expanding cultures, mESCs were 
maintained on irradiated MEF cells with media consisting of DMEM (Gibco), 15% FBS 
(Atlas Biologicals), 1X sodium pyruvate, 1X non-essential amino acids, 2X Glutamax, 
and 0.1 mM β-mercaptoethanol (all from Gibco), and 1000 U/mL LIF (ESGRO).  Cells 
used in this study were frozen at passage 8, thawed, and expanded in feeder-free 
culture conditions before organoid formation. 
 
mESC cultures 
 
Embryonic stem cells from the Pax2EGFP/+ mouse line were used to generate 
organoids between passages 13-17.  Pluripotency staining was performed at passages 
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10 and 21.  Colonies were maintained in feeder-free conditions on a 0.1% gelatin 
substrate with maintenance medium consisting of DMEM (high glucose, Gibco), 10% 
fetal bovine serum (Atlas Biologicals), 1.5 mM L-glutamine (Gibco), 5.4 mM HEPES 
(Gibco), 5.4 µM β-mercaptoethanol (Sigma), and 500 U/mL LIF (Gibco).  At passage, 
colonies were dissociated to single cells using Cell Dissociation Buffer (Gibco) with 0.5 
M EDTA solution (AccuGENE). 
 
Differentiation protocol 
 
Spherical aggregates of mESCs were differentiated according to the inner ear 
organoid protocol modified from Koehler et al. [68,69].  In brief, mESC colonies were 
dissociated to single cells and aggregated at 3000 cells per well in round-bottom 96-well 
Nunclon Sphera Microplates (Thermo Scientific) in 100 μL ectodermal differentiation 
medium.  Medium consisted of GMEM, 10% KnockOut serum replacement (KSR), 15 
mM HEPES, 1X non-essential amino acids, 1 mM sodium pyruvate (all from Gibco), and 
0.1 mM β-mercaptoethanol (Sigma).  Y-27632 (Calbiochem) was included in the 
medium at 10 μM on day 0 only. 
On day 1, half of the volume was replaced with medium containing growth factor 
reduced (GFR) Matrigel (Corning) to achieve 2% final concentration.  On day 3, 25 μL of 
medium containing SB431542 (1 μM, Stemgent) and BMP4 (10 ng/mL, Stemgent) was 
added to each well.  On day 4.5, 25 μL of medium containing LDN193189 (1 μM, 
Stemgent) and FGF2 (0, 5, 25, or 100 ng/mL, Sigma) was added to each well.  
Aggregates were transferred into a new 96-well plate in 200 μL maturation medium 
containing 1% GFR Matrigel on day 8, with half of the medium exchanged daily for the 
remainder of the protocol.  Maturation medium consisted of Advanced DMEM/F12, 1X 
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N-2 Supplement, 15 mM HEPES, and 1X Glutamax (all from Gibco).  CHIR99021 (3 
μM, Stemcell Technologies) was optionally added on day 8 as noted. 
Modifications to the Koehler et al. protocol included our use of Y-27632, use of 
10% KSR in the ectodermal differentiation medium instead of 1.5%, variation of FGF2 
dose, and use of non-enzymatic dissociation buffer for passaging and forming 
aggregates from mESCs. 
 
Immunostaining 
 
Aggregates were collected, fixed 20 minutes to overnight in 4% PFA, and rinsed 
in phosphate-buffered saline (PBS) prior to further processing. 
For staining of cryosections, fixed aggregates were cryoprotected via 30-minute 
incubations with increasing concentrations of sucrose up to 30% in PBS.  Following 
overnight incubation in 30% sucrose at 4°C, aggregates were incubated 4-5 hours in a 
1:1 mixture of 30% sucrose and OCT at room temperature, incubated 1 hour in OCT, 
and frozen in cryomolds on dry ice.  A Leica 3050S cryostat was used to section tissue 
at 10-μm thickness.  Slides were dried overnight, rehydrated in PBS for 15 minutes, and 
then transferred to humid chambers for the remainder of the staining procedure.  
Sections were blocked and permeabilized 15 minutes with 10% normal donkey serum 
(NDS) and 0.1% Triton X-100.  Primary antibodies were applied overnight at 4°C in a 
1:1 mixture of blocking/permeabilization solution with PBS.  Alexa Fluor secondary 
antibodies were applied at 1:500 in PBS for 1 hour at room temperature with slides 
covered to prevent photobleaching.  Nuclei were counterstained by 5-minute incubation 
with Hoechst 33242.  Coverslips were added with ProLong Gold Antifade Mountant 
(Molecular Probes).  For a list of antibodies used, refer to Table S1.  Control tissues 
 40 
stained without primary antibody were used to ensure that the Pax2EGFP signal would 
not preclude use of green fluorophores. 
For staining of whole-aggregate tissue, fixed aggregates were processed as 
described previously [69].  To prepare a custom imaging chamber, Sylgard 184 (1:10) 
prepared at approximately 1-mm thickness was cut to fit glass slides, and a metal punch 
was used to create a well to hold ScaleA2 solution containing a stained aggregate.  A 
coverslip was placed across the well, and the imaging chamber was sealed with clear 
nail polish. 
For staining of isolated organoids, fixed aggregates were transferred to PBS for 
microdissection of the hair cell-containing regions.  Minutien pins were used to stabilize 
aggregates against 35-mm dishes of Sylgard while hair cell-containing cysts were 
dissected using iris scissors and fine forceps.  The regions of protruding cysts distal to 
the aggregate bodies were cut open using scissors to expose the apical surfaces of hair 
cells, and the aggregate bodies were cut or teased away using scissors or forceps and 
discarded.  The hair cell-containing epithelia were retained.  Custom-made microwells 
were used to process single tissues in small solution volumes.  Organoids were blocked 
and permeabilized in PBS with 5% NDS and 0.1% Triton X-100 for 15 minutes and 
incubated in primary antibodies in blocking/permeabilization solution overnight at 4°C.  
Alexa Fluor secondary antibodies (1:500) and phalloidin conjugates (1:100) were added 
in PBS for 1 hour at room temperature, and Hoechst 33242 was applied for 5 minutes at 
1:2500 in PBS.  Organoids were mounted using ProLong Gold. 
For staining of mouse organs of Corti, 4-week-old WT and Pax2EGFP/+ mice were 
decapitated under anesthesia (80 mg/kg ketamine and 20 mg/kg xylazine).  Each 
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temporal bone was removed, and each inner ear was placed into 4% PFA.  The 
cochlear duct was then perfused with 4% PFA by perforating the cochlear windows and 
apex.  Following dissection, surface preparations of the apical turn were blocked and 
permeabilized in 5% normal donkey serum and 0.1% Triton X-100 in PBS for 1 hour at 
room temperature and incubated in primary antibody overnight at 4°C.  After extensive 
washes, the preparations were stained with Alexa Fluor secondary antibodies (1:500) 
and Alexa Fluor 488 phalloidin (1:200) for 2 hours and counterstained by a 5-minute 
application of Hoechst 33242 (1:2500).  After a final series of washes in PBS, 
preparations were mounted using ProLong Gold. 
For pluripotency staining, colonies grown on gelatin-coated coverslips or in 6-well 
culture plates were washed with PBS and fixed with 4% PFA for 15 minutes.  They were 
then blocked and permeabilized in PBS with 5-10% NDS and 0.1% Triton X-100 for 15 
minutes.  Primary antibodies were diluted in PBS or a 1:1 mixture of 
blocking/permeabilization solution for incubation at 4°C overnight.  Alexa Fluor 
secondary antibodies (1:500) were diluted in PBS for incubation at room temperature for 
1-2 hours. Hoechst 33242 was then applied for 5 minutes at 1:2500 in PBS. 
Brightfield and epifluorescence images were obtained using Leica DM IL and Olympus 
BX51WI microscopes.  Confocal images were obtained using Olympus FluoView 1000, 
Leica TCS SP5, and Leica TCS SP8 confocal microscopes. 
 
FM 4-64FX labeling 
 
For live-imaging of FM 4-64FX dye labeling, a day 20 organoid (with distal 
portion of cyst removed to expose hair cells) was dissected away from the aggregate 
body, affixed to a collagen droplet in a 35-mm dish, and maintained through day 33.  
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After dissection, the culture was maintained in serum-free medium consisting of 1X 
Basal Medium Eagle (Sigma), 2.2 g/L sodium bicarbonate, 1X insulin-transferrin-
selenium-ethanolamine (ITS-X, Gibco), 1% bovine serum albumin, 5 mg/mL glucose, 
and 8.8 U/mL penicillin G (Sigma).  A stock solution of 2 mM FM 4-64FX in distilled 
water was prepared and stored at -20°C.  The 5 μM working solution was prepared 
immediately before use by 1:400 dilution with low-calcium Hank’s Balanced Salt 
Solution (LC-HBSS), prepared by adding 0.1 mM CaCl2 to HBSS (Gibco) and filter-
sterilizing.  The organoid tissue to be labeled was rinsed in LC-HBSS, incubated 10 
seconds in FM 4-64FX working solution at room temperature, and washed three times 
with LC-HBSS for 1 minute per wash.  The time needed to add and remove the dye, 
taking care not to dislodge the tissue, and add the first wash totaled less than 30 
seconds.  Organoids were immediately imaged live in LC-HBSS. 
 
Aminoglycoside treatment 
 
Organoids were dissected and maintained on collagen droplets as described 
above.  On day 33 of culture, gentamicin (Sigma) was applied to the media at 6 μM final 
concentration.  After 72 hours, organoids were fixed in 4% PFA for 30 minutes at room 
temperature, and assayed for presence of stereocilia bundles via staining with 
rhodamine phalloidin (1:100, Thermo Fisher Scientific). 
 
FGF assay 
 
Solutions containing 1 μM LDN193189 and varying concentrations of FGF2 in 
ectodermal differentiation medium were prepared and added at day 4.5 of the 
differentiation protocol.  After brief incubation at 37°C in a humidified culture incubator 
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with 5% CO2, aggregates were collected and rinsed twice with pre-chilled PBS with 1X 
Halt Phosphatase Inhibitor Cocktail (Thermo Scientific).  Aggregates were lysed in RIPA 
Lysis and Extraction Buffer (Thermo Scientific) with 1X PI.  For lysis, aggregates were 
incubated 15 minutes on ice and sonicated on ice in three 10-second pulses at 50% 
power.  Lysates were centrifuged at 14000xg for 15 minutes and supernatants retained.  
Total protein concentration was assayed using BCA Protein Assay Kit (Thermo 
Scientific). 
 
Western blotting 
 
Lysates were diluted 1:1 with 2X Laemmli buffer from Bio-Rad (1610737) and 
denatured at 95°C for 5 minutes.  4-15% Bio-Rad Mini Protean TGX gels were loaded 
with equal amounts of total protein per well.  Molecular weight standards from Bio-Rad 
(1610317) and Cell Signaling Technology (7720) were used.  Proteins were transferred 
to nitrocellulose membranes, and membranes were blocked with 5% non-fat dry milk in 
TBS + 0.1% Tween (TBST) for 1 hour.  Primary antibody incubations were performed 
overnight in TBST at 4°C.  Horseradish peroxidase (HRP)-conjugated secondary 
antibody incubations were performed for 1 hour in TBST at room temperature.  For a list 
of antibodies used, refer to Table S1.  ECLs included SuperSignal West Pico (Thermo 
Scientific) and Amersham ECL Select (GE Healthcare).  Images were obtained using a 
FluorChem SP system (Alpha Innotech).  Densitometry was performed using Fiji 
software (version 2.0). 
 
Vesicle and organoid quantification 
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The percentage of aggregates with at least one organoid, indicated by EGFP 
signal at the base of a protruding cyst, was quantified at day 20.  The percentage of 
aggregates with at least one visible EGFP+ otic vesicle-like structure was estimated at 
day 12 using epifluorescence.  This analysis excluded vesicles not yet formed at day 12 
or not visible due to orientation away from the camera.  Since all organoids arose from 
vesicles, quantifying the percentage of aggregates with vesicles identified at day 12 or 
organoids at day 20 (referred to as “% vesicle- or organoid-positive”) more accurately 
reflected the total number of vesicle-positive aggregates.  Note that this percentage 
does not double-count aggregates in which both structures were identified. 
 
Aggregate size measurements 
 
Average long-axis diameter of 4 aggregates per timepoint was measured from 
brightfield images in Fiji software (version 2.0) [243].  Data were averaged across 
multiple cultures and plotted to track changes in aggregate size over time. 
 
Statistical analysis 
 
Statistical comparisons between two groups were performed using unpaired t-
tests in Microsoft Excel.  Comparisons amongst more than two groups were performed 
by one-way ANOVA with Tukey’s post-hoc test using the XLSTAT plug-in. 
 
RESULTS 
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Pax2EGFP/+ mice develop normal inner ears 
To develop a reporter system for monitoring otic induction during inner ear 
organoid formation, we derived mESCs from mice encoding EGFP between 5’ 
regulatory elements and the endogenous Pax2 transcription start site in one allele 
(Figure 5A) [178].  Mice with a single copy of the allele (Pax2EGFP/+) develop normal 
kidneys and midbrain-hindbrain tissues [178].  Moreover, they appear to form normal 
otic vesicles, with EGFP in the ventromedial domain where Pax2 is expressed (Figure 
5B-D’) [169], as do the majority of mouse lines carrying Pax2 loss of function alleles 
[148–150,178].  No apparent difference was seen in the gross morphology of cochlear 
and vestibular structures in Pax2EGFP/+ mice compared to WT animals (data not shown).  
To investigate more closely, we stained whole-mount preparations of the organ of Corti 
from adult Pax2EGFP/+ and WT littermates for markers of hair cells and neurons.  
Staining for Myo7a, an unconventional myosin characteristic of hair cells, and 
phalloidin-labeling of F-actin-rich hair bundles revealed the characteristic pattern of 
three rows of outer hair cells and one row of inner hair cells in both WT and Pax2EGFP/+ 
mice (Figure 5E-F’).  Tuj1 staining revealed robust peripheral projections extending 
towards the hair cells, with some continuing past the inner hair cells and into the outer 
hair cell region.  In 1 of 3 Pax2EGFP/+ embryos, we detected an aberrant pattern of 
innervation: Instead of extending radially towards the outer hair cells, multiple neurites 
traversed the tunnel of Corti at acute angles, occasionally parallel to the curvature of the 
organ of Corti.  Auditory brainstem response (ABR) testing was performed on postnatal 
mice at 4 weeks of age to measure thresholds for response to auditory stimuli.  Three 
frequencies, processed by different regions of the mouse cochlea, were presented: 8, 
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16, and 32 kHz.  Average thresholds from WT and Pax2EGFP/+ mice were not 
significantly different at any frequency (unpaired t-test, p>0.5, n=4 mice per genotype) 
(Figure 5G).  Overall, our investigation of Pax2EGFP/+ mice revealed normal auditory and 
vestibular function based on ABR testing for auditory-evoked potentials and absence of 
behavioral signs of vestibular dysfunction (e.g., circling, head bobbing, or torticollis).  
The Pax2EGFP allele, therefore, reports a normal pattern of Pax2 expression and permits 
development of the inner ear from the otic vesicle to mature auditory and vestibular 
organs in heterozygotes.  This supports the use of Pax2EGFP/+ embryonic stem cells to 
produce inner ear organoids. 
 
Pax2EGFP/+ mESCs form inner ear organoids 
 
Clonal mESCs were obtained from Pax2EGFP/+ blastocysts (clone C5, Figure 2A).  
We transitioned these cells from MEF dependence to feeder-free maintenance on 
gelatin.  At passage 10, Pax2EGFP/+ cells were screened for the pluripotency marker 
Oct3/4, which was uniformly expressed throughout colonies (Figure 6B-B’’’).  To assay 
maintenance of pluripotency, cells were stained at passage 21 for a panel of 
pluripotency markers (Figure 6C-E’’’).  Oct3/4, Sox2, and Rex1 were uniformly 
expressed, but Klf4 and Nanog were variable with regards to staining intensity and the 
percentage of positive cells, suggesting that some cells in these populations may be 
switching between naïve and epiblast-like states. 
Pax2EGFP/+ cells at passages 13-17 were evaluated for capacity to generate inner 
ear organoids (Figure 7A).  At day 0, mESC aggregates were formed, and their size 
expansion was tracked over the course of the protocol (Figures 7B and S1).  When 
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1.5% KSR was included in the ectodermal differentiation medium as per the original 
protocol, aggregates expanded at a slower rate than expected and never reached the 
1.5-2 mm diameter by day 12 described by Koehler and Hashino [69].  When 10% KSR 
was used, aggregates began at an average diameter of 320.3 ± 21.6 μm (n=21) at day 
1 and expanded to 1054.3 ± 36.0 μm by day 8 (n=11) after 100 ng/mL FGF2 was 
applied at day 4.5.  By day 20, aggregates treated in this way reached a final diameter 
of 1449.9 ± 81.7 μm (n=6).  The final diameter of aggregates treated with 25 ng/mL 
FGF2 at day 4.5 (n=5) was not significantly different (p=0.201).  Additionally, the 
inclusion of the Wnt signaling agonist CHIR99021 during early maturation did not 
appear to affect aggregate size.  For all experiments going forward, the ectodermal 
differentiation medium contained 10% KSR, a departure from the original inner ear 
organoid protocol, which may reflect a unique requirement of this cell line.   
Guided differentiation along the otic lineage was assessed via 
immunofluorescence staining of cryosections.  Following treatment with BMP4 and an 
inhibitor of TGFβ signaling SB431542 (B/S) at day 3 to encourage differentiation of non-
neural ectoderm and reduce mesoderm and endoderm, the aggregates formed a layer 
positive for E-cadherin (ECAD) and Tfap2a (AP2) (Figure 7C-F).  This layer, detected at 
day 5-6, excluded staining for brachyury and N-cadherin (NCAD), markers of 
mesendoderm and neural ectoderm, respectively. 
The addition of FGF2 and an inhibitor of BMP signaling LDN193189 (F/L) at day 
4.5 guided non-neural ectoderm toward preplacodal and, specifically, otic placodal fate.  
By day 12, otic vesicle-like structures were easily visualized due to the upregulation of 
EGFP driven by the Pax2 promoter (Figure 3G-H).  In trials of 1.5% KSR, we observed 
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Figure 5: Features of Pax2EGFP reporter system and characterization of Pax2EGFP/+ mice 
and WT controls at 4 weeks 
 
Features of Pax2EGFP reporter system and characterization of Pax2EGFP/+ mice and WT controls 
at 4 weeks postnatal.  A: Schematic for creating the Pax2EGFP allele, adapted from Soofi et al. 
2012 [178].  BamHI-NotI and Not-NcoI arms homologous to 5’ Pax2 sequence were ligated with 
an EGFP-PGK-Neo construct.  This resulted in insertion of EGFP-PGK-Neo just upstream of the 
translation start site.  Clones resistant to neomycin were obtained.  Mice expressing this 
sequence were crossed with Flippase mice, removing the PGK-Neo fragment and resulting in 
Pax2EGFP/+ mice.  Both Pax2EGFP/+ and Pax2EGFP/EGFP mESC lines were then derived.  B: 
Epifluorescence image of Pax2EGFP/EGFP (left) and Pax2EGFP/+ (right) embryos at E10.5.  EGFP 
expression marks Pax2+ tissues including otic vesicles.  C-C’: Lateral, close-up view of 
Pax2EGFP/+ embryo at E10.5.  Box in panel B marks the region shown in panels C-C’.  D-D’: 
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Isolated otic vesicle from Pax2EGFP/+ embryo.  E-F’: Immunofluorescence staining of Organ of 
Corti surface preparations from Pax2EGFP/+ and WT mice.  Mid-apical regions are shown.  In both 
genotypes, stereocilia bundles rich in F-actin and cell bodies expressing Myo7a were present in 
the typical pattern: 1 row of inner hair cells and 3 rows of outer hair cells.  Equivalent staining of 
neuronal projections marked by Tuj1 in Pax2EGFP/+ and WT tissues suggested normal 
innervation as well.  G: Thresholds for auditory evoked potentials measured by ABR testing of 
WT (dark bars) and Pax2EGFP/+ (light bars) mice.  No significant difference in sound response 
was found at any of the three frequencies presented (unpaired t-test, p>0.5, n=4 mice per 
genotype; mean ± standard deviation).  Scale bars: 1 mm (B), 200 µm (C-C’), 100 µm (D-D’), 50 
µm (E-F’). 
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Figure 6: Establishment of Pax2EGFP/+ mESC line 
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Establishment of Pax2EGFP/+ mESC line.  A: Genotyping mESC lines at the Pax2 locus.  
Blastocysts from a Pax2EGFP/+ heterozygous cross were cultured in embryonic stem cell media 
and clonally isolated.  DNA from individual clones were analyzed for the WT Pax2 allele.  PCR 
and primer pairs were as described previously [178].  The cells used in this study were from 
clone C5.  B-B’’’: Brightfield and epifluorescence images of Pax2EGFP/+ mESC colonies stained at 
passage 10.  Oct3/4 staining throughout colonies supports characterization as pluripotent, 
undifferentiated stem cells.  C-E’’’: Epifluorescence images of Pax2EGFP/+ mESC colonies 
stained at passage 21 to assay maintenance of pluripotency.  Note uniform expression of 
Oct3/4, Sox2, and Rex1 in D’’, E’’, and E’’’ but variable expression of Klf4 and Nanog in C’’, C’’’, 
and D’’’.  Scale bars: 100 µm (B-E’’’). 
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Figure 7: Process of forming Pax2EGFP/+ organoids 
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Process of forming Pax2EGFP/+ organoids.  A: Timeline of inner ear organoid formation.  
Additions of growth factor reduced (GFR) Matrigel and exogenous patterning molecules are 
indicated as well as milestones for successful cultures.  Differentiation is guided via exogenous 
factors at day 3 and day 4.5; otherwise, organoid formation occurs through self-patterning.  After 
the transfer of aggregates from ectodermal differentiation medium to maturation medium at day 
8, 50% of medium is exchanged every other day, so the percentage of Matrigel becomes 
progressively dilute over time.  The Wnt pathway agonist CHIR99021 (a GSK3β inhibitor) 
promotes formation of pre-organoid, otic vesicle-like structures when applied between days 8 
and 10 [70].  It was not necessary for our cell line, however, and was not included in our 
cultures unless noted.  B-M: Progression of aggregates through inner ear organoid protocol.  
Panels B-F and L-M exemplify aggregates treated with 25 ng/mL FGF2 at day 4.5 and without 
CHIR99021 at day 8.  The aggregate in Panel G was treated with 100 ng/mL FGF2 at day 4.5 
and without CHIR99021 at day 8.  Panels H-K exemplify aggregates treated with 100 ng/mL 
FGF2 at day 4.5 and with CHIR99021 at day 8.  B-C: Aggregates expand to over twice their 
original size and develop ruffled edges by day 4.5.  D-F: Cryosectioning and 
immunofluorescence staining at days 5-6 reveal an outer layer expressing markers of non-
neural ectoderm, E-cadherin (ECAD) and Tfap2a (AP2), and excluding markers of 
mesendoderm, Brachyury and N-cadherin (NCAD).  G-H: Epifluorescence images of 
representative vesicle-positive aggregates at day 12.  The Pax2EGFP allele permits observation 
and tracking of vesicles as they form early during the maturation phase and later migrate and 
expand into organoid-containing cysts protruding from the surface.  I-J: Adjacent cryosections 
stained for preplacodal markers Six1 and Eya1 or otic placodal markers Pax2 and Pax8.  Pax2 
signal is concentrated at vesicles, in accordance with epifluorescence imaging.  Vesicles were 
also positive for Six1 and Eya1.  Pax8 was not detected.  L-M: Brightfield and epifluorescence 
images of a representative organoid-positive aggregate at day 20.  Pax2EGFP expression 
indicates the location of hair cells at the organoid region bordering the protruding cyst and the 
body of the aggregate.  Note also the presence of a vesicle that did not expand and protrude, 
marked with an arrow.  Scale bars: 200 µm (D-H, L-M), 100 µm (B-C, I-J), 50 µm (K). 
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markedly weaker EGFP epifluorescence than in trials of 10% KSR (not shown).  In 10% 
KSR trials, EGFP signal increased gradually throughout the aggregates beginning on 
day 9 but was brighter in the vesicles compared to surrounding tissue.  Staining for 
Pax2 confirmed the uniform expression of Pax2 in vesicle epithelia as well as scattered 
expression throughout the aggregates, whereas Pax8 expression was absent at this 
same time point (Figure 7I).  Preplacodal markers Eya1 and Six1 were detected at the 
vesicle epithelia at day 12 (Figure 7J-K).  Inclusion of CHIR99021 early in the 
maturation phase (days 8-10) appeared to increase the size and number of vesicles at 
day 12 (Figure 7H) [70]; however, this condition was not necessary for vesicle formation 
using Pax2EGFP/+ cells and was not included unless otherwise noted.  Aggregates were 
observed via epifluorescence microscopy until day 20, by which time the progressive 
expansion of vesicles into protruding cysts described by Koehler et al. was replicated in 
our cultures (Figure 7L-M) [68].  The EGFP signal became concentrated at the base of 
each protrusion, bordering the aggregate body, marking the “organoid” region where 
hair cells were expected.  Overall, the Pax2EGFP/+ mESC aggregates cultured with 10% 
KSR met major checkpoints for otic differentiation and reported on formation of Pax2+ 
vesicles and organoids. 
 
Otic induction during organoid protocol supports FGF-ERK-Pax2 mechanism 
 
FGF signaling is a necessary step in the adoption of inner ear fate.  We 
investigated whether a similar relationship existed between FGF2 dose and the 
efficiency of organoid production.  Using a range of FGF2 doses (0, 5, 25, and 100 
ng/mL) at day 4.5, we maintained cultures through day 20 and quantified the 
percentage of aggregates featuring at least one organoid as defined by an EGFP+ 
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border region at the base of a protruding cyst.  A clear pattern of dose-dependency was 
observed: FGF2 was required for organoid formation, and increasing doses resulted in 
more aggregates forming organoids (Figure 8A-A’’).  The efficiency of vesicle production 
also corresponded with FGF2 dose, as expected based on our finding that all organoids 
arose from EGFP+ vesicles (Figure 8A’-B).  Using 25 ng/mL FGF2 resulted in a similar 
percentage of organoid-positive aggregates (24.1% ± 10.0) compared to the 10-20% 
reported previously [69].  The maximum dose tested, 100 ng/mL, resulted in an even 
higher percentage of organoid-positive aggregates (41.8% ± 19.8) (Figure 8B).   
FGF receptors signal through multiple downstream pathways including those 
mediated by ERK, AKT, and PLCγ.  Recent reports have demonstrated the necessity of 
ERK as a mediator of otic induction in chickens and zebrafish [241,242].  Further, the 
zebrafish study provided evidence that ERK is needed for hair cell development 
whereas AKT is involved in otic neurogenesis.  Given the correlation between vesicle 
formation and FGF2 dose, we decided to investigate whether ERK activation would 
demonstrate the same relationship.  We hypothesized that the process of otic induction 
in organoids would replicate the in vivo developmental mechanism, supporting the use 
of inner ear organoids as a model to study signaling mechanisms involved in early 
mammalian otic development. 
To examine the activation of ERK downstream of FGF2, aggregates were 
harvested at 1 hour after application of LDN193189 and varying doses of FGF2 (0, 5, 
25, and 100 ng/mL) at day 4.5.  Lysates were prepared and screened for the activated, 
phosphorylated form of ERK (pERK).  ERK phosphorylation increased in an FGF2 
dose-dependent manner (Figure 8C).  Interestingly, the strongest ERK activation was 
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induced by 100 ng/mL FGF2, a 4-fold higher dose than prescribed by the original 
organoid protocol [68,69].  These data reveal correlations between FGF2 and both 
organoid production and ERK phosphorylation, in agreement with developmental 
literature on otic induction [241,242]. 
 
Pax2EGFP/+ organoids model several features of developing ear 
 
Organoids were screened for Myo7a+ cells with F-actin+ apical structures, 
indicative of hair cells with stereocilia bundles.  Myo7a+/Pax2+ cells were found in the 
organoid regions where EGFP was observed (Figure 9A).  Cryosectioning revealed the 
presence of internal organoids containing Myo7a+ hair cells arrayed in an epithelial layer 
with F-actin+ stereocilia-like bundles oriented inward towards the central lumen of each 
cyst (Figure 9B,B’).  Protruding organoids were dissected and stained as isolated 
surface preparations.  Imaging the apical face of the preparation revealed a variety of 
bundle morphologies, with some splayed and some tightly bundled stereocilia (Figure 
5C).  A network of thick F-actin-rich belts similar to those formed by supporting cells in 
vivo invariably marked the organoid regions where hair cells were found; this distinctive 
feature served as a useful marker by which to screen tissues for hair cells efficiently. 
We screened for additional characteristics of auditory and vestibular organs to 
demonstrate the suitability of the Pax2EGFP/+ cell line for inner ear organoid formation.  
The organoid hair cells were lined basally by a layer of Sox2+ cells similar to supporting 
cells of the inner ear.  The hair cells themselves were positive for Sox2 as well (Figure 
9D).  This may be evidence of arrest at an immature stage as Sox2 is downregulated in 
auditory hair cells of neonatal mice [16,199].  Alternatively, it may point to a vestibular 
phenotype as particular vestibular hair cells express Sox2 into adulthood [222].  The  
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Figure 8: Evidence of ERK mediating FGF-driven otic induction in mouse organoid 
model 
 
Evidence of ERK mediating FGF-driven otic induction in mouse organoid model.  A: 
Quantification of aggregates with EGFP+ organoid regions at the bases of protruding cysts at 
day 20.  The percentage with organoids increased with higher doses of FGF2.  A’: 
Quantification of aggregates with EGFP+ vesicles estimated via observation of live aggregates 
by epifluorescence.  A’’: Quantification of aggregates positive either for vesicles at day 12 or 
organoids at day 20.  In panels A-A’’, N indicates the number of cultures examined, and the data 
represent mean ± standard deviation (*p<0.05).  B: Schematic illustrating percentage of original 
aggregates progressing to vesicle or organoid stages.  Note that the vesicle-positive percentage 
is taken from Figure 5A’’, since all organoid-positive aggregates progress through an 
intermediate, vesicle-positive stage.  C: Western blotting for phosphorylated ERK (pERK), total 
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ERK (tERK), and actin.  The proportion of phosphorylated-to-total ERK (pERK/tERK) increased 
with higher doses of FGF2.  Fold change in pERK/tERK relative to 0 ng/mL FGF2 baseline is 
quantified (unpaired t-test, *p<0.05; mean ± standard deviation). 
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Figure 9: Characterization of Pax2+ inner ear organoids 
 
Characterization of Pax2+ inner ear organoids.  A: Confocal z-projection showing whole-mount 
immunofluorescence of an aggregate at day 20.  Note that Myo7a+/Pax2+ cells are found at the 
border between the aggregate (dashed line) and the protrusion (solid line).  Following fixation 
and staining of tissues, the native EGFP signal was no longer observed, so fluorophores 
emitting green light could be used.  B: Myo7a+ cells with F-actin-rich bundles arranged in an 
epithelial layer, shown via both cryosection and dissected organoid preparation staining.  B’: 
Vestibular hair cells stained for Myo7a and F-actin in E15.5 C57BL/6 control mouse embryo.  C: 
Surface preparation of isolated organoid demonstrating variety of bundle morphologies.  
Vestibular-like bundles are shown in insets at higher magnification.  D: Confocal image showing 
whole-mount immunofluorescence for Sox2+ cells reveals a supporting cell layer immediately 
below Myo7a+ hair cells.  Because the hair cells are also Sox2+, they are evidently immature 
[16,199].  D’: Vestibular hair cells and supporting cells in a C57BL/6 control embryo also 
express Myo7a and Sox2 at E15.5.  E: Each stereocilia bundle in an organoid contains a single 
cilium positive for acetylated tubulin, reflecting a vestibular or immature cochlear phenotype.  F: 
FM4-64FX dye, applied for 10 seconds before wash-out, is rapidly taken up by hair cells, 
presumably through mechanotransduction channels.  Note the flask shape suggestive of type I 
vestibular hair cells [12].  Scale bars: 100 µm (A), 50 µm (B, B’, D, D’), 20 µm (C), 10 µm (E).  
FGF2 doses: 25 ng/mL (C, F), 100 ng/mL (A-B’, D, E). 
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presence of a single kinocilium, marked by expression of acetylated tubulin (AceTub), at 
each apical bundle supports characterization as either vestibular or immature auditory 
hair cells (Figure 9E). 
To test for functional mechanotransduction channels, we applied the styryl dye 
FM4-64FX to an organoid that had been dissected at day 20 and cultured until day 33 
adhered to a collagen droplet.  Following 10-second application, the dye was washed 
out, and the organoid was imaged live.  Positive labeling indicative of hair cells was 
observed (Figure 9F).  Because the dye application was brief, entry presumably 
occurred through functional mechanotransduction channels rather than via endocytosis 
or uptake through other large pores such as those from P2X receptors [244].  To test for 
susceptibility to aminoglycoside-induced ototoxicity, additional organoids cultured on 
collagen to day 33 were treated with 6 μM gentamicin for 72 hours.  Rhodamine 
phalloidin was used to screen for stereocilia bundles.  Bundles were present in 3 out of 
4 organoids in both treated and untreated conditions, indicating that the hair cells were 
not severely affected by aminoglycoside treatment (not shown). 
 
Vesicle-associated neurons model features of embryonic inner ear neurogenesis 
 
The incidence of neurons in inner ear organoids has been reported [68].  This 
prompted us to further investigate the source and synaptogenic potential of these 
neurons.  We first examined whether the neurons in our organoids arose from 
neuroblasts associated with vesicles at day 12.  Staining revealed cells expressing Islet-
1/2 (Isl1/2) immediately adjacent to vesicles positive for Pax2 (Figure 10A).  This pattern  
closely resembled Isl1/2+/Sox2+ neuroblasts delaminating from otocysts in C57BL/6 
mouse control tissue at E11.5 (Figure 6A’-A’’) [245,246]. 
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Figure 10: Comparison of immunofluorescence staining for Isl1 and SHH in day 12 
aggregates and E11.5 embryos 
 
Comparison of immunofluorescence staining for Isl1 and SHH in day 12 aggregates and E11.5 
embryos and evidence of organoid synapses.  A-A’’: Pax2 is enriched in otic vesicle of day 12 
aggregate (treated with 100 ng/mL FGF2 at day 4.5 and 3 µM CHIR99021 at day 8) and E11.5 
C57BL/6 mouse embryo relative to surrounding tissue.  Isl1/2+ cells are found adjacent to the 
vesicles in both tissues, suggesting a process of delamination in aggregates similar to cvg 
formation in embryos.  B: SHH staining is localized to specific sources in E11.5 control embryo 
at the level of the otic vesicle: the ventral neural tube (large arrowhead) and notochord (small 
arrowhead).  In panels A-B, the otic vesicle is marked by a dashed line, the neural tube is 
marked by a dotted line, and neuroblasts or putative neuroblasts are marked by arrows.  C: 
Dissected organoid preparation with neurons clustered near hair cells.  Tuj1+ projections 
traverse through the hair cell region.  D: Presynaptic Ctbp2 and postsynaptic GluA2 puncta are 
directly apposed at the base of hair cells.  E-F: Some projections appear to terminate at hair 
cells, forming bouton endings (arrowhead in E) or calyceal endings (the latter suggesting type I 
vestibular phenotype, asterisks in F).  Others continue past the hair cells, in some cases 
appearing to form en passant synapses (arrow in E).  Scale bars: 100 µm (A-B), 20 µm (C), 10 
µm (E).  CHIR99021 treatment was included in panels D-E.  FGF2 dose: 100 ng/mL (C-F). 
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In development, SHH signaling extrinsic to otic tissue impacts the specification of 
cochleovestibular ganglion (cvg) neuroblasts indirectly through Neurogenin 1, and SHH 
signaling intrinsic to otic tissue is necessary for cvg neuroblast proliferation and survival 
[187].  Given these relationships between SHH and with inner ear neurogenesis, we 
examined SHH expression in our day 12 aggregates through immunofluorescence 
staining.  SHH signal was faint and non-specific (not shown).  In contrast, SHH is readily 
detected at the ventral neural tube and notochord in E11.5 mice (Figure 10B). 
Whether or not the specification of organoid-associated neurons involves SHH, 
their ability to form synaptic contacts with hair cells is important to evaluate as this could 
be exploited in disease modeling or regeneration studies.  Tuj1+ neurons were found in 
clusters near regions of Myo7a+ hair cells within the isolated day 30 organoids (Figure 
10C).  These cells extended projections traversing the hair cell epithelia.  Furthermore, 
these cells formed putative synaptic connections on hair cells as indicated by the co-
localization of the presynaptic marker Ctbp2 and postsynaptic marker GluA2 in puncta 
at the basal aspect of hair cells (Figure 10D).  This direct apposition of presynaptic and 
postsynaptic markers mimics the one-to-one pairing of these markers in the mature 
inner ear [21,247].  To characterize the interaction between neurons and hair cells in 
our organoids, we stained for neurofilament (NF) and Tuj1 and found projections with 
terminal boutons and calyces as well as en passant synapses (Figures 10E-F).  
Altogether, these results support the potential use of inner ear organoids as a model not 
only of hair cell development but also inner ear neurogenesis. 
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DISCUSSION 
 
The generation of inner ear organoids from mouse and human pluripotent stem 
cells could transform in vitro disease modeling, drug discovery, and regenerative 
studies in auditory and vestibular research [68,71].  Adoption of the methodology is, 
however, lacking; to the best of our knowledge, all prior publications report efforts of a 
single laboratory.  For our study, we applied the method to mouse embryonic stem cells 
derived from blastocysts of a heterozygous Pax2-reporter mouse line.  The results 
reflect a dependence of otic vesicle induction on FGF concentration and support the 
vestibular-like characterization of the organoids.  Variability in the efficiency of organoid 
production over time and passaging of cells suggests that further optimization is needed 
to make this protocol more robust and translatable to a broad range of pluripotent stem 
cell lines. 
Here we demonstrated the utility of transcriptional reporter ESCs from an 
established mutant mouse line.  Direct comparison between in vivo development and in 
vitro differentiation in the same genetic background is a prototype for organoid cultures 
as model systems.  However, verifying that the reporter system recapitulates embryonic 
expression patterns and does not interfere with development is critical.  We used mouse 
ESCs with an EGFP reporter driven by the endogenous Pax2 promoter sequence.  In 
general, transcriptional regulatory elements are proximal to start sites, but some tissue-
specific enhancer elements can be located far upstream.  For example, enhancers 
within a 6.9-kb region upstream of the Pax2 transcription start site are sufficient to drive 
expression in mid-hindbrain domains, but a 30-kb 5’ region is required for expression in 
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the ear, kidney, and spinal cord [240].  Therefore, confirming that transcriptional reporter 
lines reproduce in vivo expression patterns is a necessary consideration when modeling 
development of specific tissues in vitro.  Our results showed otic expression of the 
EGFP reporter in vivo, normal phenotypic hearing thresholds of Pax2EGFP/+ mice 
compared to WT mice, and sustained expression of Pax2 from ESC-derived otic 
vesicles to sensory hair cell stages.  Since Pax2 is a marker for otic vesicles and 
terminally differentiated sensory cells in mouse development [149,169,248], the 
Pax2EGFP allele is a potential asset for future studies of  molecular events leading from 
progenitors to mature hair cells. 
Our results were consistent with evidence that Pax2 heterozygosity on C57BL/6 
background does not adversely affect formation of inner ear tissue [149].  Although 
Pax2 heterozygosity and C57BL/6 background (previously untested with this protocol) 
did not prevent organoid formation, we did find that modification of the original protocol 
was necessary.  A higher concentration of KSR was required to induce aggregate 
growth to the expected size [69], raising the possibility that KSR influences proliferation 
rate.  In two different mESC lines based on the 129 background strain, EB size did not 
change systematically with increasing KSR concentration [249].  Whether KSR affects 
proliferation during early stages of the inner ear organoid protocol and whether this is 
cell line-specific remain to be determined.  Alternatively, KSR may affect differentiation 
or competence to adopt otic lineage.  We found that higher KSR concentration was 
associated with stronger EGFP—and likely higher Pax2—expression within the vesicles 
and throughout the aggregates.  From this we infer that some component of KSR 
influenced differentiation potential in addition to or independent of aggregate growth.  
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Differential requirements of organoid cultures for KSR concentrations ranging from 1.5% 
to 20% have been described and an unidentified caudalizing factor implicated [36].  One 
candidate is insulin, a weakly caudalizing factor in SFEBq cultures [250].  The 
uncharacterized influence of each component of KSR is an important consideration in 
optimizing protocols for independent cell lines.  Though a higher concentration of KSR 
was advantageous for producing inner ear organoids with the Pax2EGFP/+ cell line, its 
components could impact the efficiency of organoid formation in conflicting ways when 
added indiscriminately. 
Inner ear organoid formation is largely dependent upon self-organization with 
limited input of exogenous patterning molecules during the maturation phase.  In 
development, secreted factors Wnt (from the dorsal neural tube) and SHH (from the 
ventral neural tube and notochord) influence dorsal-ventral patterning of otic vesicles; 
their opposing gradients establish vestibular and auditory/neurogenic domains 
[163,164,186,187,251].  Day 12 aggregates lacked a particular source of SHH 
analogous to the ventral neural tube and notochord.  In keeping with the absence of this 
ventralizing morphogen, the organoids expressed various features of vestibular-like 
end-organs.  For instance, the presence of calyceal terminals was indicative of type I 
vestibular hair cells [45].  In addition to its role in ventralization and cochleogenesis, 
SHH signaling is required for maturation of the cvg, which becomes a source of SHH 
later in development [182,211,212,214,215].  In day 12 aggregates, Isl1/2+ neurons did 
not themselves express SHH.  Given the vestibular hair cell characteristics and the 
need for auditory hair cells in clinical applications, future inner ear organoid studies 
should evaluate directed patterning of vesicles through exogenous SHH.  Additionally, 
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future studies should establish definitively whether Isl1/2+ cells originate from vesicles 
and give rise to the mature neurons found within the organoids.  Resolving this issue is 
important if inner ear organoids are to be used as a model system for disease and 
developmental studies.  Moreover, if these neurons are indeed otic in nature, then the 
protocol may ultimately provide sensory, non-sensory, and neural elements for inner ear 
repair and regeneration. 
Additional differences between mESC-derived and embryonic inner ear tissues 
represent opportunities for optimization: For instance, our gentamicin treatment 
paradigm resulted in no obvious effect on derived hair cells.  In contrast, treatment of 
neonatal mouse cochlea explants with 3.5 μM gentamicin for 72 hours results in a 
gradient of outer hair cell death, with nearly complete loss at the base of the cochlea 
[252].  We used 6 μM gentamicin based on experiments demonstrating severe loss of 
hair cells throughout cochlear explants (data not shown).  Therefore, while the inner ear 
organoid protocol resulted in a close approximation of native hair cells with regards to 
molecular, structural, and functional characteristics, refinements are still needed to fully 
replicate hair cell physiology. 
Another notable difference from embryonic tissue was absence of Pax8 staining 
in the newly formed, Pax2+ otic vesicles at day 12 of the protocol.  Pax2 and Pax8 show 
overlapping expression in the ventral domains of otic vesicles of E9.5-10.5 mice [253], 
and Pax8 expression has been demonstrated previously using the organoid culture 
protocol [68].  The lack of Pax8 may indicate a unique feature of the cell line and may 
prompt experiments on the role of Pax genes in organoid formation.  Pax2, Pax5, and 
Pax8 can compensate for one another in development, but Pax5 is not expressed in the 
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embryonic inner ear and was absent from our aggregates [150,176].  Therefore, the 
development of otic tissue in vitro relied solely on heterozygous Pax2 expression. 
 
Tracking protocol efficiency is necessary for optimization 
 
As mentioned, the adaptability of the inner ear organoid protocol to several 
distinct cell lines has been demonstrated.  DeJonge et al. optimized FGF2/LDN193189 
treatment timing for each cell line within a window of just 6 hours [70].  This showed that 
careful consideration of the relative efficiencies of different cell lines is crucial.  Our 
experience suggested that cultures vary in efficiency not only with parameters defined 
by the protocol (e.g., timing or dose of drug treatments) but with additional parameters 
yet to be elucidated.  We found that mESC passage number, reagent lots, and seasonal 
environmental fluctuations may influence outcomes.  In addition, the reliance upon 
Matrigel, an animal-derived product that varies unpredictably in composition from lot to 
lot, is not ideal, though no reliable alternative has been established. 
The data presented in this study were produced during a single period of cultures 
meeting criteria for “success” in generating otic cultures: At least 10% of aggregates 
were vesicle-positive, with some expanding into large, protruding cysts.  During that 
time, non-otic cultures (lacking one or both criteria for success) corresponded to higher 
mESC passage numbers.  It is important to note that subsequently, without changing 
materials or methods, our success rate dropped suddenly and without relationship to 
passage number for a prolonged interval.  In contrast, hair cells were reliably identified 
in the organoid region at the base of each protruding cyst in our previous and 
subsequent cultures. 
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We present a summary of our culture attempts categorized by major variations to 
the original protocol tested (Figure S2) as well as a strategy we recommend for 
adopting the inner ear organoid protocol (Table 5).  The summary corresponds to our 
trials with Pax2EGFP/+ cells only, although we tested other cell lines (R1, R1/E, and 
E14Tg2a).  As noted, our Pax2EGFP/+ cell line required 10% KSR in the ectodermal 
differentiation medium.  During the period when our cultures were consistently 
producing organoids, we performed drug treatments within ±3 hours from the timing 
prescribed by the original protocol with no adverse effects.  The combinations of 
additional variables predicted to influence the success of inner ear organoid cultures are 
myriad; this presents a challenge even when using cell lines known to be amenable to 
the protocol. 
The collective understanding of stem cell differentiation and pluripotency are still 
evolving, despite the fact that mESCs were first derived several decades ago [254,255].  
Naïve and primed states of pluripotency have recently been distinguished, and 
pharmacological means of reverting primed cells to a naïve state are being discovered 
[256–258].  Although our outcomes did not correlate with passage number, 
maintenance of naïve pluripotency is a key consideration for stem cell cultures.  
Interestingly, human ESCs are more comparable to mouse epiblast stem cells (primed) 
than to mESCs (naïve), perhaps underlying the modifications that have been necessary 
to adapt mouse organoid protocols for human cells [71,259,260].  As our study 
demonstrated, the influence of cells surrounding target tissue in 3-dimensional stem cell 
culture paradigms—in terms of both secreted factors and physical cues—is relatively 
uncharacterized.  In addition, the possibility that selecting for reporter cells may bias 
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outcomes toward higher efficiency has been suggested in retinal organoid literature 
[261].  Until we gain control over pluripotency states, environmental cues, and 
distinctions between cell lines, these remain necessary caveats for organoid 
researchers. 
Efforts to understand, refine, and apply inner ear organoid technology are still in 
early stages.  However, the potential value of reporter lines able to recapitulate 
endogenous expression patterns and restore function in vivo cannot be overstated.  The 
many parallels between the Pax2EGFP/+ organoids and true organs of hearing and 
balance are a strong impetus for continued investment in what may be a highly lucrative 
area of research.  
 
Table 5: Recommended strategy to adopt inner ear organoid protocol 
Optimized approach Evaluation 
Confirm pluripotency across multiple 
passages, and define a cut-off 
Klf4, Nanog, Oct3/4, Rex1, Sox2, 
alkaline phosphatase 
Test lot efficacy at checkpoints by omitting 
one at a time (B, S, B/S, B/S-F, B/S-L, B/S-
F/L) 
Differential aggregate morphology and 
staining for ECAD and AP2 
Optimize dose and timing of B/S and F/L 
treatments 
Staining for ECAD and AP2 
Optimize % KSR in mEB media 
Staining for Pax2 at early maturation 
phase 
Screen for vesicles and organoids by 
cryosectioning 
Track outcomes over time (seasonal 
effects), passage numbers, and lot 
numbers 
Track outcomes over time (seasonal 
effects), passage numbers, and lot numbers 
Compare against standards for 
acceptable outcomes 
Track expiration dates and storage 
conditions of all drugs 
Compare against standards for 
acceptable outcomes 
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CHAPTER 3:  Early inhibition of TGFβ signaling is necessary for derived otic 
vesicles to achieve ultimate inner ear organoid fate4 
 
INTRODUCTION 
 
The potential of stem cells lies not only in their ability to adopt a full spectrum of 
cell fates but also in their promise to revolutionize medical interventions.  The primary 
cause of sensorineural deafness is loss of inner ear sensory hair cells, which transduce 
mechanical sound stimuli into afferent electrical signals.  Addressing the underlying 
cause by regenerating hair cells from patient-derived induced pluripotent stem cells is 
envisaged as a treatment to restore auditory function. 
Interest in hair cell regeneration has exploded with the availability of stem cell 
lines.  To translate results from the laboratory to the clinic, differentiation methods must 
be well-established and refined.  A basic understanding of signaling mechanisms active 
in early embryonic development should serve as the foundation for differentiation 
protocols.  Indeed, in vitro modeling of the environmental cues within a developing 
embryo is the focus of ongoing research.  Additionally, the signaling cascades initiated 
at each stage in differentiation from stem cell to progenitor to mature cell must be 
                                            
4 This chapter represents a manuscript in preparation [74]: Schaefer SA, L Liu and RK Duncan A step in 
the right direction: Early inhibition of TGFΒ signaling is necessary for derived otic vesicles to achieve 
ultimate inner ear organoid fate. 
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understood to ensure efficiency and safety of medical applications.  In addressing these 
challenges, stem cell and developmental research inform one another. 
A differentiation protocol has been established for producing inner ear organoids 
from mouse embryonic stem cells (mESCs) [68,69].  It builds on the framework of 
serum-free floating culture of embryoid body-like aggregates with quick reaggregation 
(SFEBq) with a series of exogenous drug treatments [72,73,99].  The modifications are 
intended to mimic early developmental signaling pathways that lead to inner ear fate.  
Following the initial dissociation of mESC colonies and reaggregation into spheres, 
differentiation can spontaneously proceed towards any of the three germ layers, i.e., 
ectoderm, endoderm, or mesoderm [262].  With the first drug treatment, an inhibitor of 
the TGFβ pathway directs differentiation to favor ectoderm and limit endoderm and 
mesoderm [80,85–88,97,98].  Additional drug treatments further refine the lineage path 
toward non-neural, preplacodal, and otic placodal fate.  The efficiency at each step is 
crucial to the final yield of organoids.  Therefore, understanding and optimizing TGFβ 
inhibition is necessary to produce the large quantities of hair cells required for practical 
applications. 
In this study, we examine the effect of TGFβ inhibition on generation of otic 
tissue using the inner ear organoid protocol.  On day 3 of the protocol, the inhibitor 
SB431542 is applied, targeting TGFβ-family type I receptors ALK4, 5, and 7 [263].  
Surprisingly, we find that TGFβ pathway inhibition is not necessary for derivation of 
intermediate, otic vesicle-like structures.  Alternative drugs that inhibit TGFβ signaling 
via alternative mechanisms also permitted vesicle and organoid formation and only 
differed significantly from SB431542 in production of otic tissue at the vesicle stage.  In 
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parallel, we compare the transcriptomes of derived vesicles with and without SB431542 
treatment and the transcriptomes of E10.5 mouse otic vesicles at an equivalent point in 
development.  We find that SB431542 overall induces a shift in transcription to better 
model native tissue, while persistent differences between derived and native vesicles 
represent opportunities for further optimization of the inner ear organoid protocol.  
These observations motivate future investigation of genes regulated immediately 
downstream of TGFβ receptor activation that establish competence to achieve otic fate. 
 
MATERIALS AND METHODS 
 
mESC cultures 
The R1/E mESC line (from 129X1 x 129S1 mouse strain) was used for this 
study.  Cells from passage 18-26 were used to generate inner ear organoids.  For stem 
cell maintenance, colonies were cultured in feeder-free conditions on 0.1% gelatin in a 
medium consisting of a 1:1 mixture of Advanced DMEM/F-12 and Neurobasal, 0.5X B-
27 (without vitamin A), 1X N-2 supplement, and 1X GlutaMAX (all from Gibco) 
supplemented with 1000 U/mL LIF (Gibco) and 2i inhibitors PD0325901 (1 μM Stemcell 
Technologies) and CHIR99021 (3 μM Stemcell Technologies) within 1 week of use.  
Colonies were dissociated to single cells with TrypLE Express (Gibco) for maintenance 
and for producing aggregates. 
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Differentiation protocol 
mESC aggregates were cultured according to the previously described inner ear 
organoid protocol [68–70].  On day 0, following dissociation of colonies, cells were 
reaggregated in round-bottom 96-well Nunclon Sphera Microplates (Thermo Scientific).  
Cells were seeded at a density of 3000 cells in 100 μL ectodermal differentiation 
medium per well.  The medium was composed of GMEM, 1.5% KnockOut serum 
replacement (KSR), 15 mM HEPES, 1X non-essential amino acids, 1 mM sodium 
pyruvate (all from Gibco), and 0.1 mM β-mercaptoethanol (Sigma). 
On day 1 of the ectodermal differentiation phase, growth factor reduced (GFR) 
Matrigel (Corning) was applied at a final concentration of 2% in ectodermal 
differentiation medium by replacing half the volume in each well.  On day 3, 10 ng/mL 
BMP4 (Stemgent) was added in 25 μL medium per well, with or without TGFβ inhibition.  
Inhibitors tested included SB431542 (1 μM, Stemgent), SIS3 (3 μM, Tocris), and 
RepSox (1 μM, Tocris).  On day 4.25, 1 μM LDN193189 (Stemgent) and 100 ng/mL 
FGF2 (Sigma) were added in 25 μL medium per well. 
To begin the maturation phase on day 8, aggregates were transferred into 
maturation medium consisting of Advanced DMEM/F-12, 1X N-2 supplement, 15 mM 
HEPES (Gibco), and 1X GlutaMAX, with 1% GFR Matrigel and 3 μM CHIR99021 
(Stemcell Technologies).  Half the volume of media was exchanged daily beginning on 
day 10.  Aggregates were monitored for vesicle formation by day 12 and for organoid 
formation by day 20-22. 
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Quantification of vesicles and organoids 
The rate of vesicle production was estimated by disrupting aggregates and 
counting the vesicles released.  On day 12, 32 aggregates (from 4 columns chosen at 
random from each 96-well plate) were collected.  Aggregates were washed with 
DMEM/F-12 (with HEPES, Gibco) to remove maturation medium and resuspended in 
DMEM/F-12 containing 1X collagenase/hyaluronidase (Stemcell Technologies) in 35-
mm Nunclon Sphera dishes (Thermo Scientific).  Dishes were placed at 37°C in a 
humidified 5% CO2 culture incubator for 45 minutes.  At 15-minute intervals, aggregates 
were triturated gently with cut 1-mL pipette tips to encourage gradual disruption and aid 
diffusion of the enzymes.  After 45 minutes, an uncut tip was used to fully dissociate 
aggregates to a mixture of single cells, residual clumps, and intact vesicles.  The 
mixture was filtered through a 40-μm cell strainer, which was then inverted and washed 
with DMEM/F-12 to retrieve vesicles and clumps into a fresh 35-mm Nunclon Sphera 
dish.  Using a micropipette, vesicles were manually isolated from the clumps and 
transferred into a separate dish to prevent double-counting.  The rate of vesicle 
production was then expressed as the number of vesicles counted within 20 minutes 
divided by the number of aggregates disrupted. 
Organoids were identified through brightfield imaging by presence of translucent 
cysts between days 20 and 22.  Cysts were either protruding or internal to the 
aggregates and must have a defined epithelial border to be considered an organoid.  
The rate of organoid production was expressed as the percentage of aggregates with at 
least one cyst meeting this criterion.  At least 32 aggregates were screened per 
condition per trial. 
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Immunostaining 
At day 12 (vesicle stage) or days 20-22 (organoid stage), aggregates were 
collected and fixed 1 hour in 4% PFA.  Following fixation, aggregates were washed with 
phosphate-buffered saline PBS and stored at 4°C until further processing. 
For cryosection staining, aggregates were incubated in sucrose at increasing 
concentrations up to 30% in PBS.  Overnight incubation in 30% sucrose at 4°C was 
followed by incubation in a 1:1 mixture of 30% sucrose and OCT for at least 4 hours at 
room temperature or overnight at 4°C.  Aggregates were then transferred to OCT in 
cryomolds for a 1-hour incubation prior to being frozen on dry ice.  OCT blocks were 
sectioned using a Leica 3050S cryostat at 12-μm thickness.  Sections were dried 
overnight at room temperature.  Then, they were rehydrated with PBS for 15 minutes 
and transferred to a humid chamber for further processing.  Slides were treated for 15 
minutes with blocking/permabilization solution consisting of 10% normal donkey serum 
and 0.1% Triton X-100, then incubated overnight with primary antibodies in 1:1 PBS and 
blocking/permeabilization solution.  Slides were incubated with Alexa Fluor secondary 
antibodies at 1:500 in PBS protected from light to prevent photobleaching.  Hoechst 
33242 was used for nuclear counterstaining at 1:2500 in PBS for 5 minutes.  ProLong 
Gold Antifade Mountant (Molecular Probes) was used to apply coverslips.  Table S1 
provides a list of antibodies used in this study. 
For dissected organoid staining, fixed aggregates with protruding cysts were 
transferred a 35-mm Sylgard dish with PBS.  The hair cell-containing organoid 
epithelium at the base of a cyst was isolated using iris scissors and fine forceps and 
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placed into a custom-made microwell for staining.  Blocking and permeabilization was 
performed by 15-minute incubation with 5% NDS and 0.1% Triton X-100 in PBS.  
Organoids were then transferred to a humid chamber and incubated overnight with 
Myosin 7a primary antibody (Santa Cruz, sc-74516) in blocking/permeabilization 
solution at 4°C.  Alexa Fluor 568-conjugated donkey anti-mouse secondary antibody 
and Alexa Fluor 488 Phalloidin (Thermo Fisher Scientific) were applied at 1:500 and 
1:100, respectively, in PBS for 1 hour at room temperature with tissues protected from 
light.  Hoechst 33242 was applied at 1:2500 in PBS for 5 minutes, and organoids were 
mounted with ProLong Gold. 
For brightfield and epifluorescence imaging, Leica DM IL and Olympus BX51WI 
microscopes were used.  Additional imaging was performed using an Olympus 
FluoView 1000 confocal. 
 
Statistical analysis 
 
Comparisons between 2 groups were performed using unpaired t-tests in 
Microsoft Excel.  Comparisons amongst more than 2 groups were performed with one-
way ANOVA and Tukey’s post-hoc test in the statistical analysis software package 
SPSS 24. 
 
Isolation of derived vesicles for RNASeq 
 
On day 12 of differentiation, R1/E aggregates were disrupted using 
collagenase/hyaluronidase as described.  For RNASeq sample collection, the filtrate 
was collected in DMEM/F12 and transferred to a low-attachment dish on ice during 
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manual selection of vesicles under a dissection microscope.  Vesicles were collected in 
Buffer RLT (Qiagen) in RNase-free tubes on ice and then frozen quickly on dry ice 
before being transferred to -80°C until RNA extraction.  Selection was limited to 20 
minutes to avoid RNA degradation.  At minimum, 30 vesicles were collected from each 
biological repeat, and 3-4 biological repeats were performed per condition. 
 
Dissection of embryonic vesicles 
On E10.5, pregnant C57BL/6 dams were sacrificed, and uterine horns were 
removed and placed into PBS on ice.  From this point, PBS was replaced frequently to 
keep tissues cold.  Embryos were harvested under a microscope and then transferred 
to ice until dissected.  Otic vesicles were harvested by creating a window in the 
epithelium adjacent to the second branchial arch using a scalpel blade.  Vesicles were 
then teased away from periotic mesenchyme using fine forceps.  Isolated vesicles were 
transferred to Buffer RLT in RNase-free tubes on ice and then frozen quickly on dry ice 
before storage at -80°C.  Separate pregnant dams were used for each of the 4 
biological repeats; each repeat comprised 2-6 otic vesicles from 1-3 embryos. 
 
RNA sequencing 
Total RNA was extracted using an RNeasy Mini Kit (Qiagen) and transferred to 
the UM DNA Sequencing Core for library preparation and sequencing.  RNA input was 
assessed for quality and quantity using an Agilent Bioanalyzer 2100, Agilent 2200 
TapeStation, and NanoDrop ND-1000 spectrophotometer (Thermo Scientific).  The RIN 
scores ranged from 8-10.  cDNA libraries were prepared from 100 ng total RNA per 
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sample using a TruSeq RNA Sample Prep Kit v2 (Illumina).  Library quality was 
confirmed by TapeStation and qPCR before sequencing.  The Illumina HiSeq-2500 
platform was used to perform V4 single end, 50 bp sequencing of libraries.  Samples 
were sequenced in duplicate, with each sample loaded in two separate lanes.  Fastq 
output files generated by bcl2fastq software v2.17 (Illumina) were uploaded to the 
Galaxy web platform (http://usegalaxy.org/). 
 
Data analysis 
Data analysis was performed using Galaxy v0.4.3.1 [264].  Within Galaxy, the 
wrapper Trim Galore! v0.4.3.1 was used to assess the quality of base calls via FastQC 
v0.69 [265] and to trim and filter reads via Cutadapt v1.14.  Trimming removed low-
quality base calls (Phred < 20) before adapters, and then filtering removed short reads 
(<20 bp).  Reads were aligned to the mm10 genome assembly with HISAT2 v2.0.5.2 
[266].  The resulting BAM files were merged to combine data from duplicate lanes.  
Data were converted to raw counts (reads per transcript) with the HTSeq v0.6.1 script 
htseq-count using Ensembl annotations [267,268].  Raw counts were then normalized 
for differential expression analysis using DESeq2 v2.11.39 [269].  Normalized counts 
from DESeq2 were processed using Cluster 3.0 for preparation of heatmaps using Java 
TreeView   Additional analysis such as gene ontology (GO) was performed on HTSeq 
counts by the UM Bioinformatics Core using iPathwayGuide (p<0.05 and Log2FC>0.6). 
Data availability 
RNA sequencing data resulting from this study will be made available for 
download upon publication. 
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RESULTS 
 
R1/E mESCs produce otic vesicle-like and organoid structures 
To produce derived otic vesicles and inner ear organoids, we used the inner ear 
organoid protocol optimized for R1/E mESCs, with BMP4/SB431542 treatment at day 3 
and FGF2/LDN193189 treatment at day 4.25 (Figure 11A) [70].  First, we established 
that the R1/E cell line recapitulated major checkpoints for inner ear organoid production 
in our hands, including formation of otic vesicle-like structures in the early maturation 
phase (Figure 11B-H’).  At this time, R1/E-derived aggregates displayed translucent 
regions surrounding dense cores (Figure 11H-H’), in contrast to the overall dense 
aggregates of Pax2EGFP/+ mESCs we have previously shown [231].  Otic vesicle-like 
structures could be visualized within the translucent regions by brightfield microscopy 
before the aggregates became opaque due to continued tissue expansion.  These could 
be released from the surrounding aggregate by a combination of enzymatic and 
mechanical disruption as described in Materials and Methods (Figure 11I). 
Within intact aggregates, the vesicles themselves expanded in size, becoming 
large-fluid-filled cysts by day 20-22 (Figure 11J).  Immunofluorescence staining of 
epithelia dissected from these cysts revealed hair cell-like cells, indicating inner ear 
organoid fate (Figure 11K-L). 
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Figure 11: Formation of organoids from R1/E cell line 
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Formation of organoids from R1/E cell line.  A: Modified timeline of inner ear organoid formation 
(compare to Figure 3).  Changes from our previous experiments using Pax2EGFP mESCs include 
the following: In this study, FGF2 was always applied at 100 ng/mL, and the FGF2/BMP inhibitor 
(LDN193189) treatment was applied at day 4.25 instead of day 4.5.  The Wnt agonist 
(CHIR99021) was always included during days 8-10.  Although not shown in the figure, stem 
cell maintenance medium was changed from a classic formulation with serum and LIF to a 
newer 2i media formulation [270].  Ectodermal differentiation medium included 1.5% KSR rather 
than the 10% KSR required by Pax2EGFP aggregates.  Y-27632 was omitted at aggregate 
formation.  Finally, the reagent used to dissociate mESC colonies for was changed from non-
enzymatic buffer to TrypLE Express.  These changes were made to reproduce conditions used 
by Koehler et al. in the original inner ear organoid protocol and modifications made by DeJonge 
et al. for R1/E cells [68,70].  B-G: Changes in aggregate morphology in aggregates treated on 
day 3 with SB431542 as per the original inner ear organoid protocol.  Extensive ruffling occurred 
by day 6 as described by Koehler and Hashino [69]; ruffling was was much more pronounced 
than observed in our prior cultures with Pax2EGFP mESCs.  H-H’ Vesicles are observed in 
translucent regions early in the maturation phase.  H’ shows a magnified view of a vesicle from 
panel H.  I: Example of isolated vesicles.  J: Organoid-stage aggregate with hair cell-containing 
region outlined.  K-L: Immunofluorescence images of a cryosectioned (K) or dissected (L) 
organoid stained for hair cell markers Myo7a and F-actin.  Scale bars: A-J: 200 μm, K-L: 50 μm. 
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TGFβ signaling inhibition by SB431542 is not necessary for derived otic vesicles 
To investigate the role of TGFβ signaling in differentiation of otic tissue, we first 
examined SB431542-treated and untreated aggregates at day 12.  In parallel, we 
sought to optimize TGFβ inhibition to ensure an optimal baseline of ectoderm for 
subsequent stages of differentiation.  Therefore, we also examined aggregates treated 
with RepSox and SIS3, small molecules that inhibit TGFβ signaling via alternative 
mechanisms from that of SB431542 (Figure 12A).  Whereas SB431542 and RepSox 
block signaling at the receptor level upstream of effectors Smad2 and Smad3, SIS3 
specifically blocks activation of Smad3. 
For quantification of vesicles formed by day 12, aggregates were disrupted and 
vesicles manually selected and counted.  SB431542-treated and untreated aggregates 
produced vesicles at comparable efficiency; however, RepSox and SIS3 resulted in 
significantly more vesicles per aggregate (p<0.05) (Figure 12B).  Despite differential 
efficiency in vesicle formation, the vesicles in all conditions were qualitatively similar as 
assessed by immunofluorescence staining.  Day 12 tissues were cryosectioned and 
immunostained for 4 markers of embryonic otic vesicles: E-cadherin, Pax2, Six1, and 
Sox2.  Fluorescence imaging revealed that the translucent regions observed early in 
maturation were spaces lined by epithelia from which otic vesicles pinch away, as 
shown previously in R1 aggregates [68,70].  Positive staining of vesicles for all 4 
markers was observed in all aggregates regardless of TGFβ inhibition at day 3 (Figure 
12C-F’’’). 
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Figure 12: Comparison of TGFβ pathway inhibitor effects at vesicle stage of differentiation 
 
 84 
Comparison of TGFβ pathway inhibitor effects at vesicle stage of differentiation.  A: Schematic 
showing mechanisms of TGFβ pathway inhibition.  SB431542 targets type I receptors ALK4, 5, 
and 7.  RepSox specifically targets ALK5.  SIS3 specifically targets the effector Smad3.  Smad7 
is an endogenous inhibitor that regulates Smad-mediated signaling.  B: Quantification of 
vesicles formed by day 12 in aggregates treated with differential TGFβ inhibition at day 3.  Both 
RepSox and SIS3 produced more vesicles than SB431542 or untreated aggregates (unpaired t-
tests, *p<0.05; mean ± standard deviation).  C-F’’’: Immunofluorescence images of 
cryosectioned aggregates stained for otic vesicle markers.  Positive staining was noted in all 
conditions.  Scale bars: 100 μm (C-F’’’). 
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TGFβ signaling inhibition is necessary for inner ear organoids 
Having observed improved efficiency of vesicle formation with the alternative 
inhibitors, we then investigated potential effects on organoid formation.  Organoids form 
in the late maturation phase through the continued differentiation of vesicles; however, 
not all vesicles will necessarily become organoids.  Thus, it was necessary to test the 
assumption that the alternative inhibitors RepSox and SIS3 may improve the yield not 
only of vesicles but of organoids as well. 
We identified large, fluid-filled cysts indicative of organoids in the SB431542 
(11/12 trials), RepSox (7/7 trials), and SIS3 treatment groups (6/7 trials).  These cysts 
were either internal to the aggregates or protruding from their surfaces.  The presence 
of hair cells was confirmed in both types via immunofluorescence staining in 
cryosections or dissected tissues, respectively.  In all 3 TGFβ-inhibited groups, hair cells 
were Myo7a+ with apical F-actin+ stereocilia-like bundles and surrounded by thick F-
actin belts as in native inner ear sensory epithelia (Figure 13A-C).  The untreated group 
never produced either type of cyst (0/8 trials), and hair cells were not found in 
cryosections, which were screened in 3 of the 8 trials as a check on scoring organoid 
formation by visualization of cysts. 
We then compared the influence of SB431542, RepSox, and SIS3 on 
aggregates’ potential to form inner ear organoids.  The percentage of aggregates with at 
least one cyst was quantified.  No statistically reliable difference was observed amongst 
the 3 inhibitor groups (Figure 13D).  RepSox, however, produced the highest average 
percent organoid-positive (p=0.061, t-test compared with SB431542) and with the least  
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Figure 13: Comparison of TGFβ pathway inhibitor effects at organoid stage of differentiation 
 
Comparison of TGFβ pathway inhibitor effects at organoid stage of differentiation.  A-C: 
Confocal images of dissected organoids immunostained for hair cell markers Myo7a and F-
actin.  Myo7a+ hair cells with F-actin+ apical stereocilia bundles were noted in all tissues except 
those not treated with a TGFβ inhibitor (not shown).  D: Quantification of hair cell-containing 
organoids.  No significant difference was found, although RepSox was preferred for its tendency 
to produce more organoids with less variation in yield (unpaired t-tests, p>0.05; mean ± 
standard deviation).  Scale bars: 50 μm. 
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variation between trials, making it a candidate for replacing SB431542 in future studies, 
pending further validation. 
 
Vesicles derived from SB431542-treated cultures approach native otic vesicle 
transcriptome 
To date, SB431542 has been used to promote non-neural ectoderm in all prior 
publications of mouse and human inner ear organoid protocols [68,70,71,75,231].  We 
sought to elucidate the long-term effects it exerts on derived otic vesicles and their 
competence to form hair cell-containing organoids.  We also sought to discover new 
targets for modulation by exogenous factors to derive more native embryonic-like 
vesicles.  In doing so, we would expect to model native otic vesicle differentiation more 
closely and efficiently and to achieve auditory—not just vestibular—hair cell fate.  Day 
12 vesicles were collected from the SB431542-treated condition, referred to as BSFL 
(BMP4, SB431542, FGF2, and LDN193189), and from the untreated condition, referred 
to as BFL.  These were compared against each other as well as E10.5 otic vesicles 
harvested from C57BL/6 embryos in transcriptome analysis via RNASeq.  Differentiation 
day 12 and embryonic day 10.5 were considered analogous as vesicles have just 
formed, and neuroblasts are in the process of delaminating [182,231].  
First, the quality of RNA input and sequence reliability were assessed.  The RNA 
integrity scores ranged from 8.0-10.0, and the mean quality score (Q) for each 
sequence was at least 36.14, corresponding to a 0.024% base call error probability (P).  
At least 93.03% of bases had a quality score of 30 or higher (Table 6).  Analysis of 
sequences was performed using the Galaxy web platform [264].  The overall GC 
 88 
content of the sequences was 49-50%, revealing no major bias.  Only 0.1-0.2% of base 
pairs were trimmed due to lower quality (Q<20), and 99.1% remained in each sample 
after trimming and filtering (Table 7).  The alignment of sequences to Ensembl 
annotated transcripts was performed using HTSeq Count, with at least 96.5% of reads 
per sample mapping to a feature (Table 8).  The percentage of unique reads, indicating 
the mapped reads corresponding to a single feature, was at least 86.6%. 
Gene expression profiles of otic vesicles produced by the 3 conditions were then 
analyzed in DESeq2 and iPathway Guide.  A Venn diagram was generated to 
summarize the overlap between lists of differentially expressed genes generated from 
pairwise comparisons (Figure 14A).  Differential expression was determined at log2(fold 
change)>0.6, and significance was determined at p-value (adjusted for false discovery 
rate)<0.05.  In iPathway guide, 52636 total annotated features were examined.  The 
number of genes unique to the E10.5 (native) vs BFL (derived) comparison was the 
highest at 1668, with 1083 unique to E10.5 vs BSFL and 236 unique to BSFL vs BSFL.  
Additional sets of genes appeared in the union of 2 or 3 comparisons.  Principal 
component analysis (PCA) revealed the closeness of relationships between biological 
repeats and conditions by plotting their variation in two dimensions (Figure 14B).  The 
biological repeats in each of the 3 conditions formed discrete clusters.  In principal 
component 1 (PC1), which is the best representation of variation between samples, the 
relationship of BSFL and E10.5 clusters was closer than that of BFL and E10.5 clusters.  
Like the PCA plot, a correlation heatmap and hierarchical clustering illustrate that BSFL 
samples were closer to E10.5 than BFL samples were (Figure 14C).  Samples were 
most closely related within each condition than across conditions, indicating relative 
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Table 6: Quality of RNA input and base call output 
Sample Lane* 
Total RNA 
quality (RIN) 
Barcode 
sequence 
PF Clusters 
(reads) 
% PF 
Clusters 
Yield 
(Mbases) 
% >= 
Q30 
bases 
Mean Quality 
Score 
(Phred) 
BFL-1 1 8.5 CTTGTA 24,280,297 91.05 1,578 93.33 36.2 
BFL-1 2 8.5 CTTGTA 24,292,939 90.96 1,579 93.34 36.2 
BFL-2 1 8.0 CCGTCC 21,681,310 91.01 1,409 93.03 36.14 
BFL-2 2 8.0 CCGTCC 21,707,042 90.93 1,411 93.04 36.14 
BFL-3 1 8.4 TTAGGC 24,874,381 91.12 1,617 93.05 36.14 
BFL-3 2 8.4 TTAGGC 24,838,064 91.02 1,614 93.04 36.14 
BFL-4 1 8.2 GATCAG 27,530,756 91.19 1,789 93.22 36.18 
BFL-4 2 8.2 GATCAG 27,545,248 91.11 1,790 93.22 36.18 
BSFL-1 1 8.6 ACTGAT 27,614,354 91.14 1,795 93.28 36.19 
BSFL-1 2 8.6 ACTGAT 27,666,177 91.07 1,798 93.28 36.19 
BSFL-2 1 8.8 ATTCCT 35,022,277 90.87 2,276 93.29 36.19 
BSFL-2 2 8.8 ATTCCT 35,063,235 90.78 2,279 93.29 36.19 
BSFL-3 1 8.0 GGCTAC 32,497,568 91.14 2,112 93.12 36.16 
BSFL-3 2 8.0 GGCTAC 32,490,459 91.05 2,112 93.11 36.16 
E10-1 1 9.7 ACTTGA 30,318,211 91.11 1,971 93.22 36.18 
E10-1 2 9.7 ACTTGA 30,332,421 91.03 1,972 93.21 36.18 
E10-2 1 9.8 CGTACG 27,370,770 91.02 1,779 93.16 36.17 
E10-2 2 9.8 CGTACG 27,377,820 90.94 1,780 93.16 36.17 
E10-3 1 10.0 AGTTCC 29,853,525 90.35 1,940 93.21 36.18 
E10-3 2 10.0 AGTTCC 29,877,200 90.26 1,942 93.21 36.18 
E10-4 1 9.1 GTTTCG 28,635,237 90.63 1,861 93.23 36.18 
E10-4 2 9.1 GTTTCG 28,648,774 90.51 1,862 93.22 36.18 
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Table 7: Sequence quality determined by Fastqc and Trim Galore! 
    Fastqc Trim Galore! 
Sample Lane* Sequences 
flagged as poor 
quality 
Sequence 
length before 
trimming 
%GC % Base pairs 
quality-
trimmed** 
% Reads length-
filtered after 
trimming*** 
% Base 
pairs after 
trim/filter 
BFL-1 1 0 65 49 0.1 0.1 99.1 
BFL-1 2 0 65 49 0.1 0.1 99.1 
BFL-2 1 0 65 50 0.1 0.1 99.1 
BFL-2 2 0 65 50 0.1 0.1 99.1 
BFL-3 1 0 65 49 0.1 0.1 99.1 
BFL-3 2 0 65 49 0.1 0.1 99.1 
BFL-4 1 0 65 49 0.1 0.1 99.1 
BFL-4 2 0 65 49 0.2 0.1 99.1 
BSFL-1 1 0 65 49 0.1 0.1 99.1 
BSFL-1 2 0 65 49 0.2 0.1 99.1 
BSFL-2 1 0 65 49 0.1 0.1 99.1 
BSFL-2 2 0 65 49 0.1 0.1 99.1 
BSFL-3 1 0 65 49 0.1 0.1 99.1 
BSFL-3 2 0 65 49 0.1 0.1 99.1 
E10-1 1 0 65 49 0.1 0.1 99.1 
E10-1 2 0 65 49 0.2 0.1 99.1 
E10-2 1 0 65 50 0.1 0.1 99.1 
E10-2 2 0 65 50 0.1 0.1 99.1 
E10-3 1 0 65 50 0.1 0 99.1 
E10-3 2 0 65 50 0.1 0 99.1 
E10-4 1 0 65 49 0.1 0.1 99.1 
E10-4 2 0 65 49 0.1 0.1 99.1 
* Each sample was run in 2 lanes 
** Phred score cutoff (per base quality) = 20 
***After trimming adapters, discarded reads shorter than 20 bp 
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Table 8: Alignment of BAM file reads to annotated transcripts 
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BFL-1 79115506 97.7 51.4 3653399 1506159 1794986 72160962 91.2 43138205 
BFL-2 54629733 96.9 50.3 2959491 1767296 1725220 48177726 88.2 18155791 
BFL-3 80257772 97.6 46.8 3168302 1574902 1970412 73544156 91.6 43494776 
BFL-4 69198084 96.7 49.7 4505347 2160955 2287554 60244228 87.1 23029940 
BSFL-1 68805580 96.5 47.5 4540231 2188093 2458247 59619009 86.6 22405056 
BSFL-2 110773524 97.5 52.9 4624885 2225348 2770098 101153193 91.3 58510460 
BSFL-3 81087825 96.6 49.5 4674452 2353780 2809619 71249974 87.9 26574097 
E10-1 73969184 97.3 61.1 3324875 2357667 2036344 66250298 89.6 21903917 
E10-2 67353052 97.3 46.6 3077971 2180446 1858195 60236440 89.4 20592341 
E10-3 73832198 97.3 49.9 3138940 2458663 2027702 66206893 89.7 22917308 
E10-4 70149841 97.3 53.4 3219652 2219175 1922924 62788090 89.5 21108960 
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uniformity in biological repeats (Figure 14C).  A heatmap of significantly differentially 
expressed genes separated into 3 clusters: E10.5-enriched (C1), BFL-enriched (C2), 
and BSFL-enriched (C3) (Figure 14D).  Specific markers of otic vesicles (OV), 
neuroblasts (N), and signaling pathways (Sig) and other tissues relevant to otic 
development were identified among the 3 groups. 
GO analysis of differentially expressed genes returned generic terms related to 
organismal and developmental processes with hundreds of genes per term; the top 10 
results per comparison are shown (Table 9).  Filtering the results to ear-related terms 
did reveal differences from the broad category of ear development (in all 3 
comparisons) to the specific categories of inner ear receptor cell development and 
stereocilium organization (BSFL vs BFL).  The BSFL vs BFL comparison returned the 
largest number of ear-related terms (10 terms compared to 5 in E10.5 vs BFL and 4 in 
E10.5 vs BSFL).  The identities of genes related to inner ear development were 
examined as shown in BFL vs. BSFL and BSFL vs. E10.5 comparisons (Figure 15). 
 
DISCUSSION 
 
In this study, parallels between early stages of inner ear organoid formation and 
mouse otic development were explored.  The role of the TGFβ pathway in body axis 
patterning and germ layer specification is conserved across vertebrate and invertebrate 
species [271].  Likewise, its inhibition promotes an ectodermal lineage in mESC 
aggregates on the path toward otic fate through the inner ear organoid protocol.  
Efficiency of each step in differentiation depends upon the efficiency of the preceding 
step.  Because of this, TGFβ signaling on day 3 of the protocol is pivotal in the  
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Figure 14: Differential expression analysis of day 12 derived and E10.5 embryonic otic 
vesicles 
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Differential expression analysis of genes with log2(fold change)>0.6 and p<0.05.  A: Venn 
diagram illustrating overlap in differential expression lists from pairwise comparisons between 
conditions.  B: PCA illustrating closeness of relationships within and between conditions.  C: 
Correlation heatmap and hierarchical clustering showing levels of relatedness between 
individual samples.  D: Heatmap of differentially expressed genes separated into 3 clusters (C1, 
C2, and C3) based on enrichment in each of the 3 conditions over the other 2.  Expression data 
were normalized to maximum and minimum, giving a range of values from -1 to 1 with mean of 
0.  Particular genes of interest are highlighted to the right. 
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Table 9: GO analysis of biological processes of differentially expressed (DE) genes 
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Differentially-regulated genes related to inner ear development from GO analysis.  A: BFL (blue) 
vs BSFL (red) in left 2 columns.  B: BSFL (blue) vs E10.5 (red) in right 2 columns. 
Figure 15: Genes from GO term inner ear development 
B A 
BFL vs BSFL BSFL vs E10.5 
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production of vesicles and organoids that emerge several days later.  Given the 
fundamental role TGFβ signaling plays in embryos and in early differentiation of stem 
cells, it was a logical target to begin optimizing the inner ear organoid method to reach 
its full potential. 
In our cultures, TGFβ inhibition was necessary for vesicles to mature into hair 
cell-containing organoids.  However, derived otic vesicles were observed in the 
maturation phase with or without of TGFβ inhibition in the earlier ectodermal 
differentiation phase.  Vesicles were similar in expressing all 4 otic vesicle markers 
assayed.  Exclusion of SB431542 had no discernible impact on vesicle formation or 
character.  This was surprising given that attenuation of TGFβ signaling by endogenous 
antagonists is thought to be necessary for formation of anterior ectoderm in developing 
mouse embryos [80–84].  Epiblast explants from mice lacking Nodal, a ligand for TGFβ 
receptors, are biased towards anterior ectodermal differentiation, and the embryos fail 
to produce mesendoderm [80,85–88].  If TGFβ inhibition maximizes differentiation along 
a non-neural ectodermal lineage path and restricts mesendoderm, then the incidence of 
otic vesicle-like structures at similar rates with and without SB431542 is unexpected.  
One explanation is that our panel of otic vesicle markers may be too narrow or the 
immunostaining approach not sensitive enough to detect subtle changes in expression 
functionally significant for further differentiation. 
Another explanation would be that stem cell aggregates are not fully equivalent 
to embryos, so their ability to model all aspects of embryonic development is limited.  
Several stem cell studies have demonstrated neural differentiation through TGFβ 
pathway inhibition, however, indicating sufficiency in modeling this particular aspect of 
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development.  SB431542 has been used as a neuralizing factor in cultures of mouse 
epiblast stem cells and human embryonic stem cells [97,98,272].  LeftyA, an inhibitor to 
Nodal, was used to promote differentiation towards telencephalon fate in mESC 
aggregates [99].  Finally, Koehler et al. showed a reduction in Brachyury (a marker of 
mesoderm) and upregulation of TFAP2α (a marker of non-neural ectoderm) in 
establishing the original inner ear organoid protocol with SB431542 [68].  Our 
aggregates may have a lower baseline of TGFβ signaling at day 3 as suggested by the 
similar morphologies between our untreated and SB431542-treated aggregates from 
Koehler et al. at points during the ectodermal differentiation phase (Figure S3) [68].  In 
that case, our uninhibited cultures would represent an intermediate level of TGFβ 
signaling, sufficiently low for vesicle formation but too high for maturation of organoids.  
Differential baseline levels of activated Smad1/5/8 downstream of BMP receptors have 
been reported previously for various human stem cell lines [116].  This results in 
differential requirements for BMP4 inhibition in neural induction from hESCs [114].  A 
similar cell line-dependent variability in baseline TGFβ signaling could necessitate 
optimization of TGFβ inhibition in the inner ear organoid protocol. 
The improved efficiency of vesicle formation per aggregate with RepSox and 
SIS3 supports these inhibitors as useful alternatives to SB431542.  However, the 
increased percentage of aggregates with organoids was not statistically significant, 
although RepSox resulted in the highest percentage and least variance.  The 
discrepancy in outcomes between vesicle and organoid stages raises interesting 
possibilities: More vesicles may form within the same percentage of aggregates, or 
more aggregates may produce vesicles with fewer of the vesicles competent to become 
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organoids.  Given that increased yields of otic tissue will be necessary for downstream 
applications of the inner ear organoid protocol, the mechanism by which RepSox leads 
to increased yields of otic tissue merits further investigation.  RepSox was named for its 
ability to replace Sox2 in generating induced pluripotent stem cells (iPSCs) through the 
Yamanaka factor approach [273,274].  It does so by upregulating Nanog, which has 
been shown to restrict differentiation of neuroectoderm and mesendoderm [272].  
Whether this mechanism could have shifted ectodermal tissue toward the non-neural 
lineage, causing increased formation of derived otic vesicles, remains to be determined. 
Ligands for TGFβ receptors have been shown to produce differential outcomes 
despite activating the same effectors, Smad2 and Smad3 [275,276].  TGFβ signaling is 
subject to complex regulatory processes from ligand traps and accessory receptors at 
the cell surface to nuclear shuttling and transcriptional cofactors (see review [277]).  
Even though the TGFβ family type I receptors ALK4, 5, and 7 all signal through 
Smad2/3, targeting one of these receptors (or its corresponding ligand) is not 
necessarily expected to produce the same outcome as targeting another or all 3.  This 
was demonstrated simply in a study of Activin and Nodal in P19 cells: Treatment with 
Activin caused a significantly shorter duration of Smad2 activation than did Nodal 
treatment [278]. 
In our cultures, all 3 TGFβ inhibition strategies tested had observable effects in 
our cultures; thus, we infer some baseline of TGFβ signaling.  Using SB431542 broadly 
inhibits TGFβ receptor heterotetramer complexes whether they incorporate the type I 
receptor ALK4, 5, or 7 [263].  RepSox, on the other hand, only targets complexes 
incorporating ALK5 [279].  Since ALK5 complexes are activated by Activin and ALK7 
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complexes by Nodal, RepSox would therefore allow endogenous Nodal signaling to 
proceed uninhibited [90].  The fact that RepSox and SIS3 increased vesicle yields 
above SB431542 may be related to Smad2 activation, due either to persistent Nodal 
signaling (with RepSox) or to selective inhibition of only Smad3 (with SIS3 [280]).  
SB431542, in contrast, inhibits receptors that activate both Smad2 and Smad3.  Our 
initial hypothesis was that SIS3 may have more noticeable effects on vesicle or 
organoid formation relative to SB431542 because its mechanism of action is uniquely at 
the effector level.  However, the idea that targeting ALK5 via RepSox would lead to 
observable differences compared to inhibiting all 3 ALK receptors via SB431542 is 
reasonable given the many layers of regulation on top of the simplified ligand-receptor-
Smad model of TGFβ signaling. 
Since uninhibited aggregates ultimately failed to produce organoids, the impact 
of TGFβ inhibition was ostensibly delayed until after the vesicle stage.  This suggests an 
epigenetic mechanism.  In development, epigenetic changes have been suggested to 
explain the delay between onset of competence factors and preplacodal markers, with 
most of gastrulation occurring in the interim [130].  Embryonic stem cells show global 
DNA demethylation so that progressive epigenetic changes may underlie commitment 
to lineage paths; in addition, epigenetic mechanisms may play an active role in fate 
decisions [281,282].  Investigating epigenetic changes in the derived vesicles resulting 
from TGFβ activation several days prior is a possibility with the myriad novel 
epigenomics approaches [282].  This not only could inform optimization of the inner ear 
organoid protocol by revealing targets for demethylation to re-open blocked lineage 
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paths, for instance, but could also provide new insights into mechanisms involved in 
early embryonic development. 
 In our gene expression analysis, PCA and heat mapping revealed that, relative to 
untreated derived vesicles, SB431542-treated vesicles represented an overall shift 
towards the native E10.5 transcriptome.  In the expression levels of some genes, 
however, SB431542-treated vesicles were still more “derived” than “native-like,” as 
evidenced by the closeness of the BSFL cluster to the BFL cluster along PC1.  
Achieving a more native-like vesicle through additional optimization of the inner ear 
organoid protocol is a goal of ongoing studies.  Focusing on genes differentially 
expressed between native and derived vesicles and unaffected by TGFβ inhibition via 
SB431542 may reveal new targets for additional exogenous factors (Table S3). 
 With the rise of organoid approaches in regenerative medicine and 
developmental modeling, our ability to define molecular fingerprints for unique cell types 
is likely to become more sophisticated.  Already the stem cell research community is 
shifting towards larger sets of markers to distinguish stages of differentiation.  Our 
RNASeq dataset clearly shows differential regulation of genes between TGFβ-inhibited 
and uninhibited tissues several days after treatment of these cultures diverged.  From 
this subset of genes, a new set of criteria may emerge for defining otic vesicles that 
captures their potential to achieve hair cell fate.  Because our analysis is restricted to 
persistent mRNA transcriptome-level changes, targets of acute differential gene 
regulation remain to be discovered. 
 Some of the most striking differences in expression were in a set of genes 
related to retinoic acid (RA) signaling.  RA is implicated in patterning the anterior-
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posterior axis of the otic vesicle 
[184].  The otic placode 
epithelium is exposed to 
opposing gradients of RA 
producing and degrading 
enzymes as the placode 
invaginates to form the otic cup 
[283].  By the time the otic 
vesicle has fully formed, the 
epithelium is no longer 
responsive to RA, yet RA is 
crucial to establish anterior (e.g., Lfng and NeuroD) and posterior (e.g., Tbx1) marker 
domains within the otic vesicle [283].  Opposing roles for RA in regulation of Tbx1 have 
been reported.  In the posterior OV, RA appears to promote Tbx1 [283].  This 
relationship has also been implicated in anterior-posterior patterning of placodal tissues 
in general [284].  In other, non-placodal tissues, RA and Tbx1 are mutually repressive 
(Figure 16) [285,286].  Our data, surprisingly, fit with this non-placodal model.  Our 
analysis shows Tbx1 in a category of genes expressed more in native vesicles than in 
derived vesicles (Table S3).  Conversely, retinoic acid receptor beta (RARb) expression 
was higher in derived vesicles, and RA producing enzyme Aldh1a3 expression was 
elevated in BSFL derived vesicles.  RA catabolizing enzymes Cyp26a1 and Cyp26c1 
were expressed more in native than derived vesicles.  These observations suggest that 
Tbx1 suppression in derived vesicles may relieve inhibitory regulation of RA.  As further 
Figure adapted from Yutzey et al. 2010 [285].  Tbx1 
and RA are mutually repressive, and Tbx1 is 
necessary for Otx1 expression in the ventral otic 
vesicle.  Cyp26, RA degrading enzyme, is also 
downstream of Tbx1. 
Figure 16: Model of relationship between RA, Tbx1, 
and Otx1 
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evidence, Otx1 expression was higher in native vesicles vs derived vesicles.  Tbx1 is 
necessary for expression of Otx1 in the ventral otic vesicle [287], and both Tbx1 and 
Otx1 are necessary for morphogenesis of the inner ear [288,289].  A shift in anterior-
posterior patterning with SB431542 treatment would be logical given the major role of 
TGFβ in establishing the anterior-posterior body axis early in embryogenesis [76,79,80].  
Interestingly, the expression of anterior placodal genes Pax3, Pax6, and Pax7 is highest 
in BFL; this is unexpected as embryonic TGFβ signaling promotes posteriorization but 
may suggest dysregulation of anterior-posterior cues in derived otic tissues.  Altogether, 
our results suggest that RA signaling may be too active in derived vesicles.  Inhibition of 
RA or input of other anterior-posterior patterning molecules could be advantageous to 
promote formation of otic tissue and improve yields. 
 An additional goal of our ongoing studies is to achieve auditory hair cells rather 
than vestibular.  In development, auditory hair cells arise from ventral otic vesicle 
progenitors whereas vestibular hair cells arise from dorsal progenitors.  Thus, we 
propose to induce a shift in patterning from dorsal to ventral character in our vesicle-
stage aggregates.  Since our vesicles are more dorsal—in that they give rise to 
vestibular-like hair cells—and since native vesicles are patterned with dorsal and ventral 
aspects, our RNASeq data may reveal targets for ventralizing morphogens.  Although 
opposing gradients of Wnt and SHH from the dorsal and ventral hindbrain stand out as 
drivers of dorsal-ventral patterning in otic vesicles, they do not control patterning of all 
genes differentially required for dorsal or ventral structures.  For instance, Hmx3 is 
required for development of the vestibular inner ear [290].  Otic vesicles of E9.5 mice 
show normal dorsolateral Hmx3 expression regardless of SHH knockout or constitutive 
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activation of the Wnt effector B-catenin [162,163].  Notably, Hmx2 and 3 are significantly 
upregulated in our BSFL and native samples compared to BFL (Table S3).  This 
suggests that TGFβ signaling is related to suppression of Hmx2/3.  To our knowledge, 
whether TGFβ signaling contributes directly or indirectly to otic vesicle patterning in 
concert with Wnt and SHH has not been explored.  
Another motivation for studying downstream targets of TGFβ signaling is the idea 
that TGFβ pathway inhibition could promote regeneration in the inner ear.  This is 
inspired by an interesting parallel between inner ear and kidney development: Both 
require expression of the transcription factor Pax2.  Evidence suggests that TGFβ 
signaling is inhibitory to regeneration of kidney tubule cells following renal ischemia.  
After such an event, Pax2 is re-expressed in proliferative renal cells as damaged tissue 
is regenerated [291].  Activin, a ligand for TGFβ receptors that is also upregulated in 
ischemic renal tissue, regulates proliferation by suppressing Pax2 [291].  Revealing an 
analogous role for Pax2 in the ear, Pax2 knockout mice form otic vesicles, but their 
cochlear ducts fail to extend due to reduced proliferation and increased apoptosis [148–
150].  In sum, the idea that TGFβ inhibition may be useful in inner ear regeneration, 
supported by evidence in the kidney, is worth exploring by elucidating targets of TGFβ 
signaling. 
 Overall, the large sets of differentially-regulated genes in our analysis reflect the 
foundational role of germ layer specification early in embryonic development.  Neural 
tube, neural crest, and placodal derivatives all originate from definitive ectoderm.  
Therefore, our study may facilitate future research focused on modeling development of 
these tissues.  Understanding TGFβ signaling will be especially beneficial to inner ear 
 105 
research as it may lead to generating large quantities of hair cells for in vitro studies and 
for developing in vivo hair cell replacement therapy.
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CHAPTER 4: Discussion of key findings and ongoing studies  
 
The preceding two chapters presented results of experiments addressing key 
questions about modeling inner ear development with a 3-dimensional stem cell-based 
approach.  Our questions focused on the role of FGF and TGFβ signaling pathways.  
Ultimately, our observations—both directly and indirectly related to these pathways—
prompted many follow-up questions for future research.  We also recognized the utility 
of the inner ear organoid protocol for asking novel questions not necessarily related to 
embryonic development.  In this chapter, our major findings and the potential for direct 
follow-up studies will be discussed.  Finally, this chapter will describe the pilot studies 
we have initiated in developmental modeling and other applications of the organoid 
technology. 
 
DISCUSSION OF KEY FINDINGS 
In Chapter 2, we demonstrated that mESCs modified with the Pax2EGFP allele 
were valuable in investigating otic induction during formation of inner ear organoids.  
Nascent derived otic vesicles could be monitored easily using epifluorescence 
microscopy.  Epifluorescence imaging of live tissues and immunofluorescence staining 
of cryosections indicated diffuse Pax2 expression throughout the aggregates; however, 
the EGFP signal was clearly brightest at the vesicles.  The vesicles could then be 
observed over time in live culture as they developed into large, hair cell-lined cysts.  The 
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Pax2EGFP reporter is additionally useful in selecting vesicles isolated using the 
collagenase-hyaluronidase method described in Chapter 3, providing quick confirmation 
that the selected vesicles express Pax2.  Future studies may include disruption of 
vesicles to single cells, followed by fluorescence-activated cell sorting to purify otic 
progenitors for additional downstream assays or applications.  Establishing the utility of 
this cell line is significant alone: ES lines derived from C57BL/6 mouse strains had not 
previously been tested, and stem cell lines can vary in their responses to differentiation 
cues.  As we observed, Pax2EGFP/+ aggregates differed from R1/E aggregates in terms 
of morphology; this was important to note since morphological features from R1 cells 
were previously described as criteria for successful inner ear organoid cultures. 
Using Pax2EGFP/+ aggregates, we showed that within the hour after FGF2 is 
applied on day 4.5 to promote otic fate, ERK phosphorylation occurs.  This supports the 
mechanism of ERK-mediated, FGF-driven otic induction proposed in avian and 
zebrafish developmental literature [241,242].  Strengthening this evidence was the 
dose-dependent relationship we found between FGF2 and ERK phosphorylation.  To 
establish that activated ERK is necessary for otic induction, future work should include 
inhibition of the ERK pathway using a pharmacological agent such as PD98059, which 
targets MEK, the kinase that phosphorylates ERK.  If this pathway is necessary for hair 
cell formation, then inhibition of parallel pathways involving AKT and PLCγ, which are 
also activated downstream of FGF receptors, may be beneficial: Since AKT is 
implicated in otic neurogenesis, it may direct cells away from hair cell fate toward otic 
neuronal fate.  Inhibiting this would, in theory, maximize the population of progenitors 
directed to become hair cells. 
 108 
The fact that the inner ear organoid protocol produces both hair cells and 
neurons can be considered a feature since it opens the possibility of modeling synapse 
formation and function.  The origin of inner ear organoid neurons had not previously 
been studied.  To address the nature of these neurons, we asked whether they originate 
from derived otic vesicles.  Indeed, we found Islet1/2+ cells adjacent to the vesicles, 
evocative of delaminating neuroblasts in embryonic development.  Future investigation 
using a fate-mapping approach could be used to settle this question by marking cells 
originating from vesicles.  Nonetheless, finding evidence of an additional parallel with 
embryonic inner ears suggests additional utility of the protocol in developmental 
modeling of otic neurogenesis.  Furthermore, it may lead to high-throughput generation 
of auditory and vestibular neurons for academic and clinical use. 
By dissecting the organoid region away from an aggregate, we were able to 
demonstrate uptake of the styryl dye FM4-64FX by derived hair cells after a brief, 10-
second application.  This suggested mechanotransduction channel expression [244], 
motivating more intensive future investigation through simultaneous deflection of 
stereocilia bundles and electrophysiological recording.  While improving efficiency is an 
important step in extending this protocol to the clinic, so, too, is ensuring that derived 
hair cells are functionally equivalent to native hair cells. 
Remarkably, the inner ear organoid protocol reproduces many features of an 
inner ear sensory epithelium.  However, our experiences also exposed limitations of the 
current protocol and opportunities for improvement.  Though the protocol can generate 
organoids at high efficiency (in terms of % organoid-positive aggregates), this depends 
upon competence of the tissue to respond to differentiation cues at each step.  Some 
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indications of competence are readily assayed.  For instance, stem cells should express 
markers of pluripotency, and the non-neural ectodermal layer should express E-
cadherin and AP2.  We found that successful formation of organoids could be prevented 
by some factor or factors that we and others using the protocol have been unable to 
predict.  In time, the issue seems to resolve, suggesting the influence of a seasonal 
variable such as temperature or humidity.  These variables could directly affect the 
culture environment, resulting in inconsistent evaporation rates and therefore 
inconsistent concentrations of media components.  They could also affect the 
production of animal-derived reagents (e.g., Matrigel).  To move forward, we outlined 
best practices for monitoring and, when possible, ensuring success of the protocol in 
Table 5.  Testing of synthetic reagents may help to resolve additional issues as new 
products are constantly being developed, some intended for use with the profusion of 
novel organoid approaches. 
Other unpredictable features of the cultures represent opportunities rather than 
roadblocks for future research.  The maturation phase of the inner ear organoid protocol 
occurs with vesicles developing into organoids in context of surrounding tissues that 
presumably provide physical and molecular signaling cues.  We envision isolating 
vesicles using the enzymatic and mechanical approach we devised and culturing them 
separately in defined conditions.  Vesicles could be embedded in an extracellular matrix 
or tunable hydrogel allowing for adjustment of stiffness.  Reagent-soaked beads could 
then be positioned to supply diffusible factors in directional gradients.  This would allow 
modeling the otic vesicle patterning that produces dorsal (vestibular sensory), ventral 
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(auditory sensory), and antero-ventral (neural) populations of vesicle-derived tissue.  
Additional cues could be tested for their potential involvement in patterning as well. 
Of particular interest to us is recapitulating the gradient of SHH that favors ventral 
inner ear fates.  In our aggregates, we were unable to demonstrate a distinct source of 
SHH analogous to the ventral neural tube or notochord.  This suggests that the 
aggregates do not recapitulate otic vesicle patterning in a self-directed manner.  SHH 
signaling may still occur at a level permissive of neuroblast formation, but the 
directionality that normally contributes to dorsal-ventral patterning appears to be absent.  
Mimicking the spatial arrangement of signaling cues will likely be necessary to produce 
specific hair cell types or to favor differentiation and survival of neurons, and this will 
likely require a directed approach during the maturation phase. 
In Chapter 3 of this thesis, we showed that otic vesicles were derived with or 
without TGFβ inhibitor treatment on day 3.  This was unanticipated, prompting questions 
about the role of the TGFβ pathway in early embryonic germ layer specification.  The 
idea that it promotes mesoderm and endoderm while inhibiting ectoderm may be an 
oversimplification.  One possibility is that TGFβ receptor activation results in epigenetic 
effects that restrict terminal differentiation of ectodermal derivatives without preventing 
the formation of definitive ectoderm or ectoderm-derived progenitors.  Thus, our 
untreated aggregates could have produced ectoderm competent to form otic vesicles 
that were, then, not competent to achieve hair cell fate due to an epigenetic 
modification.  Testing this hypothesis is a potential focus of investigation that could 
reveal important insight into developmental mechanisms involving the TGFβ pathway 
and epigenetic restriction of fates.  Alternatively, our unanticipated observation may 
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reflect cell line-specific differences in basal TGFβ signaling.  This would be akin to cell-
line specific baseline levels of activated Smad1/5/8, the effectors of BMP signaling, 
revealed in various stem cell lines [116]. 
One goal of our future work is to isolate otic progenitors from day 12 vesicles for 
implantation into a deafened auditory epithelium.  We hypothesize that in situ signaling 
cues will encourage integration and differentiation to repopulate the sensory epithelium.  
The increased efficiency of vesicle production (in terms of number of vesicles per 
aggregate) makes SIS3 and RepSox tempting alternatives to SB431542 for 
implantation.  While we preferred RepSox for its tendency to produce organoid-positive 
aggregates with less variable efficiency, neither RepSox nor SIS3 resulted in a 
statistically reliable increase in organoid production above SB431542.  One possible 
explanation is that although more vesicles are present, the surrounding tissue is not 
providing the correct types or levels of cues conducive to hair cell differentiation.  
Another explanation is that the vesicles themselves are less responsive to those cues.  
Thus, we must consider whether the increased number of vesicles produced by RepSox 
would be responsive to in situ signaling cues following implantation.  Therefore, 
additional work is necessary to evaluate the vesicles produced by RepSox-treated 
cultures.  We propose adding a RepSox condition to our RNASeq comparative analysis.   
The fact that the mechanism of TGFβ signaling inhibition impacted otic 
differentiation, at least at the vesicle stage, argues for a closer investigation of TGFβ 
signaling.  This pathway can involve multiple receptors, effectors, and regulatory 
proteins at each point between the ligands and transcriptional targets.  Understanding 
the signaling processes involved in inner ear development is important as we attempt to 
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recapitulate these in stem cell cultures.  Optimizing TGFβ signaling inhibition, the first 
step of directed differentiation in the inner ear organoid protocol, will contribute to 
ultimate efficiency of organoid production.  It may also contribute to producing otic 
progenitors that are most competent to respond to later stages of differentiation and 
maturation. 
Our RNASeq study represents the first transcriptome-level comparison of stem 
cell-derived and native otic tissue.  Of the thousands of differentially expressed genes 
between derived and native samples, we focused on those with relatively high fold 
changes to ascertain major differences that could be targeted in a refined approach.  
Several of the highest fold changes were related to RA signaling.  RA is involved in 
anterior-posterior patterning of the otic vesicle [283].  Genes positively related to RA 
signaling (i.e., those encoding receptor RARb and synthesizing enzyme Aldh1a3) were 
enriched in derived samples, whereas genes negatively related (i.e., those encoding the 
catabolizing enzymes Cyp26a1 and Cyp26c1) were enriched in native samples.  
Interestingly, the RA target gene Tbx1 (a marker of the posterior OV) and its 
downstream target Otx1 were less expressed in the derived samples.  Overall, this 
suggests an inhibitory relationship in derived tissues, with RA reducing expression of 
Tbx1 and, therefore, Otx1.  Mutual repression of Tbx1 and RA has been described in 
non-placodal tissues such as the neural crest and pharyngeal arches [285,286].  This 
model, however, is at odds with one proposed for RA signaling in placodal tissues [284], 
including the otic placode [283]: In these tissues, RA is thought to promote Tbx1.  Thus, 
our derived tissues unexpectedly fit with a non-placodal model of retinoic acid signaling. 
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In embryonic development, otic tissue loses responsiveness to RA as the otic 
cup invaginates and the otocyst forms [283].  Furthermore, the RA-synthesizing and 
catabolizing enzymes influential for the anterior-posterior patterning effects are not 
localized to the otic tissue but rather expressed in adjacent mesoderm and ectoderm, 
respectively [283].  Thus, apparent differences in native and derived expression could 
be biased by carryover of adjacent tissue.  To directly assess the potential influence of 
elevated RA signaling in our derived tissues, we propose to use mESCs modified with a 
reporter for a response element of RA.  If our vesicles are, in fact, influenced by 
excessive RA signaling, then inhibiting this pathway would better model native 
embryonic conditions. 
The overall highest fold changes we found were in Hmx2 and Hmx3 expression, 
with significant enrichment in SB431542-treated derived and native vesicles compared 
to uninhibited vesicles.  This suggested a relationship between TGFβ inhibition and 
upregulation of these genes.  Hmx2 and Hmx3 are expressed in the dorsolateral otic 
vesicle and required for vestibular inner ear development [162,163,290].  To our 
knowledge, direct involvement of TGFβ signaling in otic vesicle patterning has not 
previously been described.  This evidence underscores the importance of optimizing our 
first step in directed differentiation through SB431542 or alternative inhibitors.  As noted 
above, in addition to its early role in germ layer specification, TGFβ could potentially 
induce epigenetic changes that restrict the adoption of specific cell fates in later stages 
of differentiation.  For instance, by regulating Hmx2/3, it may bias precursors on the 
path toward vestibular hair cell fate.  Determining the mechanism of later-stage effects 
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of TGFβ inhibition (after initial specification of ectoderm) is a subject of interest.  The 
long-term nature of these effects suggests investigation using epigenomics approaches. 
 
ONGOING STUDIES 
Even with the conclusion of these experiments, the potential of inner ear 
organoids is only beginning to be realized.  In vitro modeling of mammalian embryonic 
development is a tractable, scalable, and overall more convenient alternative to in vivo 
studies.  Aggregates throughout the inner ear differentiation protocol could be used to 
work out the multiple roles that molecules like SHH, Wnt, Sox2, Pax2, and others are 
suggested to play in mammalian inner ear development.  Modeling damage or disease 
through ototoxic drugs, genetic aberrations (potentially through introducing mutations 
with CRISPR), or other challenges to inner ear physiology would be a highly valuable 
for biomedical research.  Organoids could be used to test Notch pathway inhibitors to 
promote transdifferentiation of Sox2+ supporting cells or to test additional regeneration 
strategies.  These long-term goals necessitate optimization of the inner ear organoid 
protocol.  Modifications to the protocol to tailor it to auditory vs vestibular fates and to 
improve overall yields are a major focus of ongoing efforts. 
Opportunities for follow-up studies to our experiments were delineated above and 
in the preceding chapters.  In addition, our lab has pioneered studies illustrating the 
broad range of future directions for inner ear organoid research: 
1) Coculturing organoids with sections of mouse brainstem at the level of cochlear 
nuclei to study synapse formation in collaboration with Dr. Michael Roberts 
(KHRI, UM).  The inner ear organoids are associated with neurons that may, as 
our imaging data suggests, delaminate from the vesicular epithelium and that do 
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appear to form synaptic contacts with the derived hair cells.  We are interested in 
investigating whether these neurons can establish the next synaptic connection 
in the afferent pathway toward central auditory processing in the brain.  
Therefore, we obtained slices from mouse brainstem at the level of the cochlear 
nucleus and established conditions to culture these adjacent to isolated 
organoids (Figure 17A-D).  We observed outgrowth of processes from the 
organoids, extending toward the 
brainstem slices (Figure 17E-F).  
Notably, in the absence of a 
brainstem slice, processes 
extending from the organoid 
explant did not extend radially 
but rather encircled the explant.  
Future experiments would 
investigate synaptic 
connections, for example, using 
fluorescent tracer such as 
Fluoro-Ruby to illuminate 
network structure or using a 
calcium indicator for network 
activity.  This system could be 
used to model reinnervation of a 
deafened epithelium, examine 
Figure 17: Preliminary testing of brainstem 
coculture 
A: Preparation of cochlear nucleus (CN)-
containing brainstem slice.  B: Preparation of 
isolated organoid.  C: Schematic of coculture 
system on Transwell membranes.  D: Example 
of brainstem slice (left) and organoid (right) in 
culture on Transwell membrane.  E: Tuj1 
staining of organoid showing outgrowth of 
neuronal processes.  F: Tuj1 staining showing 
both brainstem and organoid, with Tuj1+ 
processes traversing the space between them. 
A B 
DC 
FE 
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synapse formation, predict integration of regenerating tissue with the CNS, or to 
improve outcomes with cochlear implants through regrowth of peripheral 
processes to be stimulated by the electrodes. 
2) Implanting organoids under kidney capsule in mice to promote maturation in a 
physiological environment, as has been performed with lung and intestinal 
organoids, in collaboration with Dr. Jason Spence (CDB, UM).  The Spence lab 
has demonstrated that human intestinal organoids, derived from hESCs in vitro 
and engrafted under the mouse kidney capsule, undergo significant expansion 
and maturation of intestinal cell types [292].  Our labs collaborated to test this 
approach to maturation of our inner ear organoids, since the hair cells seem to 
arrest at an immature state.  We recovered the tissue after a maximum of 5-6 
weeks and sectioned and stained for hair cell markers.  Locating hair cells within 
the tissue was extremely challenging, and evidence from our coculture 
experiments suggested that the organoids may not thrive when exposed to 
serum.  If the number of hair cells per organoid prior to engraftment can be 
optimized by other means, then this strategy or a similar strategy for maturation 
would be worth revisiting.  The Spence lab has also used a synthetic scaffold as 
an alternative to support culture and maturation of lung organoids, which also do 
not thrive when engrafted into the kidney [293].  This might provide a suitable 
environment for maturation of our organoids as well.  
 117 
3) Implanting derived otic progenitors obtained from vesicle-stage aggregates into 
guinea pig ears to repopulate deafened auditory epithelia in collaboration with Dr. 
Yehoash Raphael (KHRI, UM).  
Towards the goal of regenerating a 
sensory epithelium in a deafened ear, 
we have performed pilot experiments 
using R1 mESCs stably expressing 
EGFP.  These were implanted into 
the scala media as single cells either 
at the stem cell stage or the otic 
progenitor stage (from day 12 
vesicles derived using the organoid 
protocol, disrupted using enzymatic 
and mechanical means).  The scala 
media is first prepared by injection 
with the loop diuretic furosemide to 
poison potassium pumping 
mechanisms and by flushing out the 
harsh, high-potassium endolymph 
with a standard extracellular medium.  Sodium caprate is then used to break tight 
junctional barriers in the deafened auditory epithelium to promote integration of 
the implanted cells (Figure 18A).  24 hours after implantation, we observed 
clusters of EGFP+ stem cells (Figure 18B) and of EGFP+ derived otic progenitors 
Figure 18: Implantation of R1-EGFP 
mESCs and derived otic progenitors into 
deafened guinea pig cochlea 
A: Preparation of guinea pig to receive 
implanted cells.  The scala media is 
prepared using furosemide and 
extracellular medium to disrupt the 
normally harsh high-potassium 
environment.  Sodium caprate is used to 
promote cell integration of cells into the 
flat deafened epithelium.  Cells are then 
injected into the scala media.  B-C: 
EGFP+ cells from undifferentiated ES 
stage (B) or otic progenitor stage (C) are 
found after 24 hours. 
A 
B C 
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(Figure 18C).  These pilot experiments provide encouraging evidence of cell 
survival.  Our goal is to repeat this approach over a longer period to allow time 
for the cells to integrate and differentiate in context of a pro-otic environment.  
4) Treating aggregates with additional morphogens such as SHH to induce 
ventralization of vesicles and produce auditory hair cells.  Ongoing experiments 
in the lab are investigating the effect of SAG, an agonist to the SHH receptor 
Smoothened, and SANT-2, an antagonist to the same receptor, on the dorsal-
ventral patterning of derived otic vesicles (Figure 19A).  These cues are provided 
between day 10-12 of the organoid protocol, and vesicles are collected for qPCR 
analysis of dorsal and ventral markers and SHH-responsive genes (Figure 19B).  
So far, we have observed upregulation of SHH pathway markers Gli1, Hhip1, and 
Figure 19: Evaluation of gene expression changes with SHH 
pathway modulators in derived otic vesicles 
A: Schematic of endogenous factors implicated in dorsal-ventral patterning 
of the mammalian embryonic otic vesicle.  B: Results of preliminary qPCR 
testing, showing differential regulation of SHH-responsive genes in 
vesicles from cultures treated with a SHH pathway agonist (SAG) or 
antagonist (SANT-2). 
B A 
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Ptch1 resulting from SAG.  Correspondingly, we have observed downregulation 
of these markers resulting from SANT-2.  Additional analyses of dorsal-ventral 
markers and, at later stages, vestibular and auditory markers will be performed.  
Considerations for widespread adoption of the organoid protocol include cell line 
differences that necessitate fine-tuning the doses and timing of drug treatments.  This 
has been demonstrated by the optimization of FGF2/LDN193189 application within a 
12-hour window [70].  Better modeling of the embryonic environment with a less 
variable product than Matrigel would be advantageous; toward this end, we have tested 
an alternative called BME2 (Amsbio) but found it to be no more effective than Matrigel.  
In adapting strategies from development for stem cell differentiation, the use of synthetic 
molecules is preferred due to their relative stability and affordability.  These must be 
tested to ensure they replicate mechanisms of endogenous molecules without 
unintended effects.  Many other labs have attempted to produce organoids without 
success; basic knowledge of stem cell pluripotency and priming are still catching up with 
labs aspiring to perform in translational research.  Yet, the results presented here are 
some of the most promising examples of hair cells derived entirely in vitro compared to 
others published thus far.  Since these results are possible and the downstream 
applications would be so lucrative, the reliable production of inner ear organoid cultures 
is a worthwhile pursuit. 
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Appendix 
 
Supplemental Figures and Tables 
Figure S1: Tracking increase in aggregate diameter during ectodermal differentiation 
phase
 
Tracking increase in aggregate diameter during ectodermal differentiation phase.  
Measurements of long-axis diameter were made from 4 random aggregates and averaged 
across multiple cultures.  Aggregates cultured with 10% KSR and treated with 100 ng/mL FGF2 
were measured at day 1, 3, 5, 8, and 20 (n=21, 6, 7, 11, and 6, respectively; mean ± standard 
deviation).  Treatment with 25 ng/mL did not result in a difference in aggregate size as shown by 
measurements at days 8, 12, and 20 (n=1, 1, and 5, respectively; mean with ± standard 
deviation shown for day 20).  Aggregates cultured with 1.5% KSR and treated with 25 ng/mL 
FGF2 were measured at day 1, 6, and 8 (n=2 each; mean). 
 
 
 
 
 121 
Figure S2: Tracking inner ear organoid culture success rate with Pax2EGFP/+ mESCs 
 
Tracking inner ear organoid culture success rate with Pax2EGFP/+ mESCs.  Major changes to the 
protocol tested during troubleshooting efforts are indicated.  Results are separated into 3 
groups: those obtained during a period of reliably successful cultures (from June 2015-Feb 
2016), those obtained during a brief period of mixed otic and non-otic cultures (March 2016), 
and those obtained during a subsequent prolonged period of non-otic cultures with few, qualified 
successes.  A culture was considered successful if at least 10% of aggregates formed vesicles 
and at least some of these became large, protruding cysts.  Early cultures reliably contained 
hair cells in the organoid regions.  In contrast, of the 2 cultures after March 2016 that resulted in 
cysts (of 13 total cultures), neither resulted in detectable hair cells.  Changes to the protocol 
tested during this period included preparing BMP4 with 0.1% BSA as a carrier, omitting Y-27632 
from ectodermal differentiation medium at the time of aggregate formation, using TrypLE to 
dissociate mESC colonies rather than non-enzymatic dissociation buffer, using 1.5% KSR in 
ectodermal differentiation medium, and including 2i (1 µM PD0325901 and 3 µM CHIR99021 
[270]) in the mESC maintenance medium.  These changes were made to faithfully replicate the 
methods of Koehler et al.  An additional strategy was to test a different supplier of BMP4 on the 
basis of anecdotal evidence of variation in BMP4 potency between lots.  The attempts shown in 
this figure are not independent, but the low percentage of qualified success during the April 
2016-Feb 2017 period highlights that none of the changes made was a sole determinant of 
success. 
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Figure S3: Early aggregate morphologies with and without SB431542 
 
Early aggregate morphologies with and without SB431542.  Brightfield images of aggregates at 
days 4.25, 5, and 6.  Similarity between our untreated aggregates at days 4.25-5 and Koehler et 
al’s SB431542-treated aggregates at days 5-6 prompted further investigation of the role of this 
pathway in our cultures [68].  Scale bars: 50 µm. 
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Table S1: Antibodies and stains used in Chapter 2 
Immunostaining 
Target Supplier Catalog number Host Dilution 
Acetylated Tubulin* Sigma T7451 Mouse 1:500 
AP2 
Developmental 
Studies Hybridoma 
Bank 
3B5 Mouse 1:50 
Brachyury R&D AF2085 Goat 1:20 
Ctbp2 
BD Transduction 
Labs 
612044 Mouse 1:100 
E-cadherin Cell Signaling 3195 Rabbit 1:200 
Eya1 Santa Cruz sc-15094 Goat 1:50 
F-actin (Alexa Fluor 
488 Phalloidin) 
Thermo Fisher 
Scientific 
A12379  1:100 
F-actin (Rhodamine 
Phalloidin) 
Thermo Fisher 
Scientific 
R415  1:100 
FM 4-64FX 
Thermo Fisher 
Scientific 
F34653  5 μM 
GluA2 EMD Millipore MAB397 Mouse 1:1000 
Hoechst 33242 Invitrogen 62249  1:2500 
Islet-1/2 
Developmental 
Studies Hybridoma 
Bank 
39.4D5 Mouse 1:500 
Myosin 7a Santa Cruz sc-74516 Mouse 1:100 
Myosin 7a** Proteus 25-6790 Rabbit 1:100 
N-cadherin BD 610920 Mouse 1:100 
Neurofilament*** EMD Millipore AB5539 Chicken 1:1000 
Pax2 Biolegend 901001 Rabbit 1:200 
Pax2 Invitrogen 71-6000 Rabbit 1:150 
Pax8 Santa Cruz sc-81353 Mouse 1:50 
SHH 
Developmental 
Studies Hybridoma 
Bank 
5E1 Mouse 1:10 
Six1 Sigma HPA001893 Rabbit 1:1000 
Sox2 Santa Cruz sc-17320 Goat 1:100 
Tuj1 Covance MRB-435p Rabbit 1:300 
Tuj1** Sigma T2200 Rabbit 1:200 
Pluripotency assay 
Klf4 R&D Systems AF3158 Goat 1:200 
Nanog Abcam ab80892 Rabbit 1:100 
Oct3/4 Santa Cruz sc-8628 Goat 1:50 
Rex1 
Thermo Fisher 
Scientific 
PA5-27567 Rabbit 1:200 
Sox2 Santa Cruz sc-17320 Goat 1:100 
Western blotting 
Actin 
Cell Signaling 
Technology 
4967 Rabbit 1:1000 
pERK 
Cell Signaling 
Technology 
9106 Mouse 1:500 
tERK 
Cell Signaling 
Technology 
9102 Rabbit 1:1000 
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Table S2: Antibodies and stains used in Chapter 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target Supplier Catalog number Host Dilution 
ECAD CST 3195 Rabbit 1:200 
F-actin (Alexa Fluor 
488 Phalloidin) 
Thermo Fisher 
Scientific 
A12379  1:100 
Hoechst 33242 Invitrogen 62249  1:2500 
Myosin 7a Santa Cruz Sc-74516 Mouse 1:100 
Pax2 Invitrogen 71-6000 Rabbit 1:150 
Six1 Sigma HPA001893 Rabbit 1:1000 
Sox2 Santa Cruz Sc-365823 Mouse 1:100 
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Table S3: Analysis of genes with fold change at least 1.5 and p<0.05 
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